PhilM personal page - To The Moon

PhilM

PhilM

No personal profile

2Follow

1Followers

0Topic

0Badge

2021-03-11

Way to go J&J!! ?

J&J’s one-shot Covid vaccine approved in Europe but supply questions linger

2021-03-10

Thanks to J&J’ vaccine. Just one doze!

Biden administration to buy an additional 100 million doses of J&J's Covid vaccine

2021-03-09

Yes

Sorry, the original content has been removed

2021-03-09

Exciting. Watch this space. Do you agree?

Sorry, the original content has been removed

2021-03-08

Very possible

U.S. on 'tipping point of another surge,' COVID-19 experts warn

2021-03-08

The rest should follow NZ lead

New Zealand to buy enough Pfizer COVID-19 vaccines for entire population

2021-03-07

Great stuff

U.S. Stocks open up, as strong jobs report boosts reopening optimism

2021-03-07

Interesting

What's the Outlook for Intuitive Surgical?

2021-03-07

Makes sense

Buy this dip in Apple, Microsoft and these other tech stocks before they're out of reach, says analyst

2021-03-07

Woah

Sorry, the original content has been removed

2021-03-07

They need to catch up to survive

The Next Tesla May Emerge From This Explosion Of New EV Stocks

2021-03-07

Low blow

Sorry, the original content has been removed

2021-03-06

Nice!

Sorry, the original content has been removed

2021-03-06

Nice!

Sorry, the original content has been removed

2021-03-05

Setback

Apple faces EU charges over Spotify complaint: Sources

2021-03-04

EVs are the future. Watch this space.

Sorry, the original content has been removed

2021-03-04

Hmmm, not sure about this.

Facebook ends ban on political advertising across its network

2021-03-04

This is progress and innovation!! Will we see more of this in other countries also?

Sorry, the original content has been removed

2021-03-04

Oh no

Sorry, the original content has been removed

2021-03-04

Here we go!

Wall Street drops as high-flying tech stocks retreat

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3577252837038057,"uuid":"3577252837038057","gmtCreate":1614159919549,"gmtModify":1614222960298,"name":"PhilM","pinyin":"philm","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":2,"tweetSize":45,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":321724336,"gmtCreate":1615472099425,"gmtModify":1704783233535,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Way to go J&amp;J!! ?","listText":"Way to go J&amp;J!! ?","text":"Way to go J&J!! ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321724336","repostId":"1124370726","repostType":4,"repost":{"id":"1124370726","pubTimestamp":1615469642,"share":"https://www.laohu8.com/m/news/1124370726?lang=&edition=full","pubTime":"2021-03-11 21:34","market":"us","language":"en","title":"J&J’s one-shot Covid vaccine approved in Europe but supply questions linger","url":"https://stock-news.laohu8.com/highlight/detail?id=1124370726","media":"cnbc","summary":"KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by","content":"<div>\n<p>KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson.\nThe approval adds another weapon to the armory in use against the virus.\nSupply ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J’s one-shot Covid vaccine approved in Europe but supply questions linger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J’s one-shot Covid vaccine approved in Europe but supply questions linger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-11 21:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson.\nThe approval adds another weapon to the armory in use against the virus.\nSupply ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.cnbc.com/2021/03/11/jjs-one-shot-covid-vaccine-approved-by-europe.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1124370726","content_text":"KEY POINTS\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson.\nThe approval adds another weapon to the armory in use against the virus.\nSupply issues are expected to arise with this vaccine too, however.\n\nEurope’s drug regulator on Thursday approved the one-dose coronavirus vaccine created by Johnson & Johnson, adding another weapon in the armory being used to fight Covid-19.\nThe vaccine has the added benefit of only requiring a single dose and can be stored in most standard refrigerators at temperatures of 2 to 8 degrees Celsius (or roughly 36 to 46 degrees Fahrenheit), making it easier and cheaper to transport and store.\nOnce supplies start to be delivered, the shot could greatly bolster Europe’s struggling immunization program and is the fourth to be approved by the EMA. Two-dose vaccines developed by Pfizer-BioNTech,Moderna and AstraZeneca and the University of Oxford have also been approved.\nWhile it’s easier to distribute, the vaccine has not been found to be as effective as Pfizer and Moderna’s shots at preventing Covid infection. Nonetheless, the data shows it offers a decent level of protection:Clinical trial data from the U.S. has shown J&J’s vaccine is 72% effective at guarding against moderate to severe Covid(although it was found to be less potent in trials elsewhere, giving it an overall effectiveness of 66%), compared with about 95% for the other two vaccines.\nThe speed at which the EU will be able to roll out the J&J vaccine is not yet clear. The EU has ordered 200 million doses of the shot, with the option for 200 million more, Johnson & Johnson said in a statement last October.\nOn Wednesday, however, it was reported that, like other vaccine suppliers to the EU (Pfizer-BioNTech and AstraZeneca), supplies of the J&J vaccine to the bloc could be slower-than-expected.\nOne unnamed EU official told Reuters that Johnson & Johnson has told the EU it is facing supply issues that may complicate plans to deliver 55 million doses of its vaccine to the bloc in the second quarter of the year. CNBC has contacted J&J for further comment on the report and is yet to receive a response.\nFor its part, the European Commission, the EU’s executive arm, said on Wednesday that it has not been informed about any delays from J&J.\nA further delay in vaccine supplies would exacerbate the EU’s already lethargic vaccination rollout, which has struggled due to a slower ordering process than the U.K. and U.S., slower deliveries, bureaucracy and vaccine hesitancy.\nIn the U.S., J&J has a deal with the U.S. government to provide 100 million doses by the end of Juneand, on Wednesday, the Biden administration announced plans to buy 100 million additional doses.The announcement came as the White House works to ramp up production of the vaccine after it learned earlier in the year that the company had fallen behind in output.\nLast week,Biden announced that pharmaceutical giant Merck would help make J&J’s Covid vaccine. Under the arrangement, Merck will dedicate two facilities in the U.S. to J&J’s vaccine. One will make the vaccine and the other will provide “fill-finish” services, when the vaccine is placed in vials.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321016080,"gmtCreate":1615385012940,"gmtModify":1704781980446,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Thanks to J&amp;J’ vaccine. Just one doze!&nbsp;","listText":"Thanks to J&amp;J’ vaccine. Just one doze!&nbsp;","text":"Thanks to J&J’ vaccine. Just one doze!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321016080","repostId":"1129292669","repostType":4,"repost":{"id":"1129292669","pubTimestamp":1615384190,"share":"https://www.laohu8.com/m/news/1129292669?lang=&edition=full","pubTime":"2021-03-10 21:49","market":"us","language":"en","title":"Biden administration to buy an additional 100 million doses of J&J's Covid vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1129292669","media":"cnbc","summary":"The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two admi","content":"<div>\n<p>The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two administration sources told NBC News.、\nPresident Joe Biden will announce the plans Wednesday during a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden administration to buy an additional 100 million doses of J&J's Covid vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden administration to buy an additional 100 million doses of J&J's Covid vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-10 21:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two administration sources told NBC News.、\nPresident Joe Biden will announce the plans Wednesday during a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1129292669","content_text":"The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two administration sources told NBC News.、\nPresident Joe Biden will announce the plans Wednesday during a White House meeting with executives from J&J and Merck.\nJ&J currently has a deal with the U.S. government to provide 100 million doses by the end of June. The federal government shipped out nearly 3.9 million doses of the single-shot vaccine last week and says it plans to distribute 16 million more by the end of this month.\nThe announcement comes as the administration works to ramp up the production of J&J’s vaccine after it learned earlier in the year that the company had fallen behind in vaccine production.\nThe New York Times first reported in January that unexpected manufacturing delays would lead to a reduced initial supply of J&J’s drug if it were given emergency authorization.\nLast week,Biden announced that pharmaceutical giant Merck would help make J&J’s Covid vaccine. Under the arrangement, Merck will dedicate two facilities in the U.S. to J&J’s vaccine. One will make the vaccine and the other will provide “fill-finish” services, when the vaccine is placed in vials.\nWhite House Chief Medical Advisor Dr. Anthony Fauci said last month he was “disappointed” with the number of doses initially expected from J&J, adding the federal government thought there would be “considerably more.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329529374,"gmtCreate":1615260176798,"gmtModify":1704780256947,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329529374","repostId":"1176892747","repostType":4,"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329520817,"gmtCreate":1615260116439,"gmtModify":1704780255817,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Exciting. Watch this space. Do you agree?","listText":"Exciting. Watch this space. Do you agree?","text":"Exciting. Watch this space. Do you agree?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329520817","repostId":"1185442017","repostType":4,"isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329094195,"gmtCreate":1615186136217,"gmtModify":1704779252987,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Very possible","listText":"Very possible","text":"Very possible","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329094195","repostId":"2117165264","repostType":4,"repost":{"id":"2117165264","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615164660,"share":"https://www.laohu8.com/m/news/2117165264?lang=&edition=full","pubTime":"2021-03-08 08:51","market":"us","language":"en","title":"U.S. on 'tipping point of another surge,' COVID-19 experts warn","url":"https://stock-news.laohu8.com/highlight/detail?id=2117165264","media":"Dow Jones","summary":"New variants spreading faster than vaccines are being administered, and now is no time to ease restr","content":"<p>New variants spreading faster than vaccines are being administered, and now is no time to ease restrictions, Fauci and others say</p>\n<p>Another coronavirus surge could be right around the corner, U.S. public health officials say, and now is not the time to relax COVID-19 restrictions.</p>\n<p>Dr. Anthony Fauci, the nation's top infectious disease expert, said Sunday that while the numbers of daily new infections are significantly less than January, they have plateaued at what is still a very high number.</p>\n<p>\"Historically, if you look back at the different surges we've had, when they come down and then start to plateau at a very high level, plateauing at a level of 60 to 70,000 new cases per day is not an acceptable level. That is really very high,\" Fauci said in an interview on CBS's \"Face the Nation.\"</p>\n<p>\"And if you look at what happened in Europe a few weeks ago, they're usually a couple of weeks ahead of us in these patterns, they were coming down too, then they plateaued. And over the last week or so, they've had about a 9% increase in cases.\"</p>\n<p>A number of states have recently eased restrictions as infection rates have fallen from the peaks of the winter COVID-19 surge. California is planning to reopen schools .</p>\n<p>Fauci warned mitigation measures should be eased slowly and carefully -- \"But don't turn that switch on and off because it really would be risky to have yet again another surge, which we do not want to happen because we're plateauing at a- quite a high level.\"</p>\n<p>His concerns were echoed by infectious-diseases specialist Dr. Celine Gounder, who warned that new, more contagious variants of COVID-19 are spreading rapidly, especially the B.1.1.7 variant, first discovered in the U.K.</p>\n<p>\"That strain is increasing exponentially. It's spiking up,\" Gounder told CNN . \"So we are probably right now on a tipping point of another surge.\"</p>\n<p>Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, told NBC's \"Meet the Press\" on Sunday said the current vaccination rate just isn't fast enough to stop the spread of the new variants.</p>\n<p>\"We are in the eye of the hurricane right now,\" Osterholm said. \"Things are going very well, we see blue skies.\" But the U.K. variant \"is about to come upon us,\" he said. \"Today it's wreaking havoc in parts of Europe.\"</p>\n<p>Osterholm said the U.K. variant has grown from 1% to 4% of all U.S. cases about a month ago to about 30% to 40% now. \"What we've seen in Europe, when we hit that 50% mark, you see cases surge.\"</p>\n<p>To counter the threat, Osterholm said the U.S. must not let up on coronavirus restrictions, and must work to vaccinate the population even faster.</p>\n<p>Fauci said the U.S. is on the right track, though. \"Every day that goes by that we keep the lid on things will get better and better, because we're putting now at least 2 million vaccinations into the arms of individuals each day. ... So we're going in the right direction. We just need to hang in there a bit longer.\"</p>\n<p>As of late Sunday, the U.S. has recorded 28.9 million cases of COVID-19, and nearly 525,000 deaths, according to data from Johns Hopkins University . Both are, by far, the most of any country in the world.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. on 'tipping point of another surge,' COVID-19 experts warn</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. on 'tipping point of another surge,' COVID-19 experts warn\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-08 08:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>New variants spreading faster than vaccines are being administered, and now is no time to ease restrictions, Fauci and others say</p>\n<p>Another coronavirus surge could be right around the corner, U.S. public health officials say, and now is not the time to relax COVID-19 restrictions.</p>\n<p>Dr. Anthony Fauci, the nation's top infectious disease expert, said Sunday that while the numbers of daily new infections are significantly less than January, they have plateaued at what is still a very high number.</p>\n<p>\"Historically, if you look back at the different surges we've had, when they come down and then start to plateau at a very high level, plateauing at a level of 60 to 70,000 new cases per day is not an acceptable level. That is really very high,\" Fauci said in an interview on CBS's \"Face the Nation.\"</p>\n<p>\"And if you look at what happened in Europe a few weeks ago, they're usually a couple of weeks ahead of us in these patterns, they were coming down too, then they plateaued. And over the last week or so, they've had about a 9% increase in cases.\"</p>\n<p>A number of states have recently eased restrictions as infection rates have fallen from the peaks of the winter COVID-19 surge. California is planning to reopen schools .</p>\n<p>Fauci warned mitigation measures should be eased slowly and carefully -- \"But don't turn that switch on and off because it really would be risky to have yet again another surge, which we do not want to happen because we're plateauing at a- quite a high level.\"</p>\n<p>His concerns were echoed by infectious-diseases specialist Dr. Celine Gounder, who warned that new, more contagious variants of COVID-19 are spreading rapidly, especially the B.1.1.7 variant, first discovered in the U.K.</p>\n<p>\"That strain is increasing exponentially. It's spiking up,\" Gounder told CNN . \"So we are probably right now on a tipping point of another surge.\"</p>\n<p>Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, told NBC's \"Meet the Press\" on Sunday said the current vaccination rate just isn't fast enough to stop the spread of the new variants.</p>\n<p>\"We are in the eye of the hurricane right now,\" Osterholm said. \"Things are going very well, we see blue skies.\" But the U.K. variant \"is about to come upon us,\" he said. \"Today it's wreaking havoc in parts of Europe.\"</p>\n<p>Osterholm said the U.K. variant has grown from 1% to 4% of all U.S. cases about a month ago to about 30% to 40% now. \"What we've seen in Europe, when we hit that 50% mark, you see cases surge.\"</p>\n<p>To counter the threat, Osterholm said the U.S. must not let up on coronavirus restrictions, and must work to vaccinate the population even faster.</p>\n<p>Fauci said the U.S. is on the right track, though. \"Every day that goes by that we keep the lid on things will get better and better, because we're putting now at least 2 million vaccinations into the arms of individuals each day. ... So we're going in the right direction. We just need to hang in there a bit longer.\"</p>\n<p>As of late Sunday, the U.S. has recorded 28.9 million cases of COVID-19, and nearly 525,000 deaths, according to data from Johns Hopkins University . Both are, by far, the most of any country in the world.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117165264","content_text":"New variants spreading faster than vaccines are being administered, and now is no time to ease restrictions, Fauci and others say\nAnother coronavirus surge could be right around the corner, U.S. public health officials say, and now is not the time to relax COVID-19 restrictions.\nDr. Anthony Fauci, the nation's top infectious disease expert, said Sunday that while the numbers of daily new infections are significantly less than January, they have plateaued at what is still a very high number.\n\"Historically, if you look back at the different surges we've had, when they come down and then start to plateau at a very high level, plateauing at a level of 60 to 70,000 new cases per day is not an acceptable level. That is really very high,\" Fauci said in an interview on CBS's \"Face the Nation.\"\n\"And if you look at what happened in Europe a few weeks ago, they're usually a couple of weeks ahead of us in these patterns, they were coming down too, then they plateaued. And over the last week or so, they've had about a 9% increase in cases.\"\nA number of states have recently eased restrictions as infection rates have fallen from the peaks of the winter COVID-19 surge. California is planning to reopen schools .\nFauci warned mitigation measures should be eased slowly and carefully -- \"But don't turn that switch on and off because it really would be risky to have yet again another surge, which we do not want to happen because we're plateauing at a- quite a high level.\"\nHis concerns were echoed by infectious-diseases specialist Dr. Celine Gounder, who warned that new, more contagious variants of COVID-19 are spreading rapidly, especially the B.1.1.7 variant, first discovered in the U.K.\n\"That strain is increasing exponentially. It's spiking up,\" Gounder told CNN . \"So we are probably right now on a tipping point of another surge.\"\nMichael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, told NBC's \"Meet the Press\" on Sunday said the current vaccination rate just isn't fast enough to stop the spread of the new variants.\n\"We are in the eye of the hurricane right now,\" Osterholm said. \"Things are going very well, we see blue skies.\" But the U.K. variant \"is about to come upon us,\" he said. \"Today it's wreaking havoc in parts of Europe.\"\nOsterholm said the U.K. variant has grown from 1% to 4% of all U.S. cases about a month ago to about 30% to 40% now. \"What we've seen in Europe, when we hit that 50% mark, you see cases surge.\"\nTo counter the threat, Osterholm said the U.S. must not let up on coronavirus restrictions, and must work to vaccinate the population even faster.\nFauci said the U.S. is on the right track, though. \"Every day that goes by that we keep the lid on things will get better and better, because we're putting now at least 2 million vaccinations into the arms of individuals each day. ... So we're going in the right direction. We just need to hang in there a bit longer.\"\nAs of late Sunday, the U.S. has recorded 28.9 million cases of COVID-19, and nearly 525,000 deaths, according to data from Johns Hopkins University . Both are, by far, the most of any country in the world.","news_type":1},"isVote":1,"tweetType":1,"viewCount":255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329094392,"gmtCreate":1615186114716,"gmtModify":1704779253150,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"The rest should follow NZ lead","listText":"The rest should follow NZ lead","text":"The rest should follow NZ lead","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329094392","repostId":"2117665091","repostType":4,"repost":{"id":"2117665091","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615172463,"share":"https://www.laohu8.com/m/news/2117665091?lang=&edition=full","pubTime":"2021-03-08 11:01","market":"us","language":"en","title":"New Zealand to buy enough Pfizer COVID-19 vaccines for entire population","url":"https://stock-news.laohu8.com/highlight/detail?id=2117665091","media":"Reuters","summary":"SYDNEY, March 8 (Reuters) - New Zealand will buy additional COVID-19 vaccines, developed by Pfizer I","content":"<p>SYDNEY, March 8 (Reuters) - New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc    and Germany's BioNTech   , which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday.</p><p>The government has signed an agreement to buy an extra 8.5 million doses, enough to vaccinate over 4 million people, Ardern said, adding the vaccines were expected to reach the country in the second half of the year.</p><p>\"This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19,\" Ardern said in a statement.</p><p>The government's original agreement with Pfizer was for 1.5 million doses, enough to vaccinate 750,000 people.</p><p>Ardern said the decision to make Pfizer the country's primary vaccine provider was taken after it was shown to be about 95% effective at preventing symptomatic infection.</p><p>New Zealand started its national rollout of the Pfizer-BioNTech's COVID-19 vaccine last month and expects to inoculate its entire population by the end of the year.</p><p>With just over 2,000 confirmed COVID-19 cases and 26 deaths, New Zealand largely contained the pandemic compared with other developed countries, helped by speedy tracking systems, border closures and snap lockdowns.</p><p>Auckland, New Zealand's biggest city, emerged on Sunday from a strict week long lockdown imposed after a community cluster of the more contagious British coronavirus variant.</p><p>It reported no new cases on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand to buy enough Pfizer COVID-19 vaccines for entire population</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand to buy enough Pfizer COVID-19 vaccines for entire population\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-08 11:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SYDNEY, March 8 (Reuters) - New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc    and Germany's BioNTech   , which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday.</p><p>The government has signed an agreement to buy an extra 8.5 million doses, enough to vaccinate over 4 million people, Ardern said, adding the vaccines were expected to reach the country in the second half of the year.</p><p>\"This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19,\" Ardern said in a statement.</p><p>The government's original agreement with Pfizer was for 1.5 million doses, enough to vaccinate 750,000 people.</p><p>Ardern said the decision to make Pfizer the country's primary vaccine provider was taken after it was shown to be about 95% effective at preventing symptomatic infection.</p><p>New Zealand started its national rollout of the Pfizer-BioNTech's COVID-19 vaccine last month and expects to inoculate its entire population by the end of the year.</p><p>With just over 2,000 confirmed COVID-19 cases and 26 deaths, New Zealand largely contained the pandemic compared with other developed countries, helped by speedy tracking systems, border closures and snap lockdowns.</p><p>Auckland, New Zealand's biggest city, emerged on Sunday from a strict week long lockdown imposed after a community cluster of the more contagious British coronavirus variant.</p><p>It reported no new cases on Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117665091","content_text":"SYDNEY, March 8 (Reuters) - New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc    and Germany's BioNTech   , which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday.The government has signed an agreement to buy an extra 8.5 million doses, enough to vaccinate over 4 million people, Ardern said, adding the vaccines were expected to reach the country in the second half of the year.\"This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19,\" Ardern said in a statement.The government's original agreement with Pfizer was for 1.5 million doses, enough to vaccinate 750,000 people.Ardern said the decision to make Pfizer the country's primary vaccine provider was taken after it was shown to be about 95% effective at preventing symptomatic infection.New Zealand started its national rollout of the Pfizer-BioNTech's COVID-19 vaccine last month and expects to inoculate its entire population by the end of the year.With just over 2,000 confirmed COVID-19 cases and 26 deaths, New Zealand largely contained the pandemic compared with other developed countries, helped by speedy tracking systems, border closures and snap lockdowns.Auckland, New Zealand's biggest city, emerged on Sunday from a strict week long lockdown imposed after a community cluster of the more contagious British coronavirus variant.It reported no new cases on Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320600460,"gmtCreate":1615086692050,"gmtModify":1704778559391,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great stuff","listText":"Great stuff","text":"Great stuff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320600460","repostId":"1116017255","repostType":4,"repost":{"id":"1116017255","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1614954925,"share":"https://www.laohu8.com/m/news/1116017255?lang=&edition=full","pubTime":"2021-03-05 22:35","market":"us","language":"en","title":"U.S. Stocks open up, as strong jobs report boosts reopening optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=1116017255","media":"老虎资讯综合","summary":"(March 5) Stocks were set to rebound after a stronger-than-expected jobs report boosted optimism abo","content":"<p>(March 5)&nbsp;Stocks were set to rebound after a stronger-than-expected jobs report boosted optimism about a faster economic reopening.</p><p>The Dow up 0.93%, the S&amp;P 500 rose 1.05%, and the Nasdaq Composite jumped 1.13%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5a0f3bfa9164920f4899e3f22741e69\" tg-width=\"1242\" tg-height=\"572\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 09:30</span></p><p>The U.S. 10-year Treasury yield popped above 1.6% after the February jobs report. The Labor Department on Fridayreportedthat nonfarm payrolls jumped by 379,000 for the month and the unemployment rate fell to 6.2%. That compared to expectations of 210,000 new jobs and the unemployment rate to hold steady from the 6.3% rate in January, according to Dow Jones.</p><p>As rates jumped, tech shares with high valuations got hit again in the premarket, continuing the pattern this week. Tesla and Peloton shares fell declined.</p><p>The move in futures followed a sharp sell-off on Thursday triggered by Federal Reserve Chair Jerome Powell’s remarks on rising bond yields. The Fed chair said the recent runup caught his attention but he didn’t give any indication of how the central bank would rein it in. Some investors had expected Powell to signal his willingness to adjust the Fed’s asset purchase program.</p><p>The economic reopening could&nbsp;“create some upward pressure on prices,” Powell said in a Wall Street Journal webinar Thursday. Even if the economy sees “transitory increases in inflation … I expect that we will be patient,” he added.</p><p>“Equity investors, in our conversations, are really grappling with two things they may not have had to deal with for the last 10 years,” said Tom Lee, Fundstrat’s co-founder head of research. “One is the potential for inflation to actually have to be priced into equities. I think there’s a lot of confusion.”</p><p>“Then it’s a bond market that seems to be testing the Fed, which kind of scares people,” added Lee, who believes the sell-off this week is a buying opportunity.</p><p>Tech stocks led the market decline Thursday, especially those with high valuations and small or no profitability. The Nasdaq Composite dropped 2.1% Thursday, bringing its losses this week to 3.6%. The tech-heavy benchmark also turned negative for the year and fell into correction territory, or down 10% from a recent high, on an intraday basis.</p><p>Tesla shares were off their lows in Friday premarket trading but still down 0.3%.</p><p>The S&amp;P 500 and the Dow both fell more than 1% Thursday, headed for a losing week. Energy outperformed with a 2.5% gain in the previous session amid a jump in oil prices.</p><p>“Rates soared once again, which opened the door for more selling of technology stocks,” said Ryan Detrick, chief market strategist at LPL Financial. “The bright side is the economy continues to improve and leadership from financials and energy is something that suggests this isn’t a sell everything moment.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stocks open up, as strong jobs report boosts reopening optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stocks open up, as strong jobs report boosts reopening optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-05 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(March 5)&nbsp;Stocks were set to rebound after a stronger-than-expected jobs report boosted optimism about a faster economic reopening.</p><p>The Dow up 0.93%, the S&amp;P 500 rose 1.05%, and the Nasdaq Composite jumped 1.13%.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5a0f3bfa9164920f4899e3f22741e69\" tg-width=\"1242\" tg-height=\"572\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 09:30</span></p><p>The U.S. 10-year Treasury yield popped above 1.6% after the February jobs report. The Labor Department on Fridayreportedthat nonfarm payrolls jumped by 379,000 for the month and the unemployment rate fell to 6.2%. That compared to expectations of 210,000 new jobs and the unemployment rate to hold steady from the 6.3% rate in January, according to Dow Jones.</p><p>As rates jumped, tech shares with high valuations got hit again in the premarket, continuing the pattern this week. Tesla and Peloton shares fell declined.</p><p>The move in futures followed a sharp sell-off on Thursday triggered by Federal Reserve Chair Jerome Powell’s remarks on rising bond yields. The Fed chair said the recent runup caught his attention but he didn’t give any indication of how the central bank would rein it in. Some investors had expected Powell to signal his willingness to adjust the Fed’s asset purchase program.</p><p>The economic reopening could&nbsp;“create some upward pressure on prices,” Powell said in a Wall Street Journal webinar Thursday. Even if the economy sees “transitory increases in inflation … I expect that we will be patient,” he added.</p><p>“Equity investors, in our conversations, are really grappling with two things they may not have had to deal with for the last 10 years,” said Tom Lee, Fundstrat’s co-founder head of research. “One is the potential for inflation to actually have to be priced into equities. I think there’s a lot of confusion.”</p><p>“Then it’s a bond market that seems to be testing the Fed, which kind of scares people,” added Lee, who believes the sell-off this week is a buying opportunity.</p><p>Tech stocks led the market decline Thursday, especially those with high valuations and small or no profitability. The Nasdaq Composite dropped 2.1% Thursday, bringing its losses this week to 3.6%. The tech-heavy benchmark also turned negative for the year and fell into correction territory, or down 10% from a recent high, on an intraday basis.</p><p>Tesla shares were off their lows in Friday premarket trading but still down 0.3%.</p><p>The S&amp;P 500 and the Dow both fell more than 1% Thursday, headed for a losing week. Energy outperformed with a 2.5% gain in the previous session amid a jump in oil prices.</p><p>“Rates soared once again, which opened the door for more selling of technology stocks,” said Ryan Detrick, chief market strategist at LPL Financial. “The bright side is the economy continues to improve and leadership from financials and energy is something that suggests this isn’t a sell everything moment.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116017255","content_text":"(March 5) Stocks were set to rebound after a stronger-than-expected jobs report boosted optimism about a faster economic reopening.The Dow up 0.93%, the S&P 500 rose 1.05%, and the Nasdaq Composite jumped 1.13%.*Source From Tiger Trade, EST 09:30The U.S. 10-year Treasury yield popped above 1.6% after the February jobs report. The Labor Department on Fridayreportedthat nonfarm payrolls jumped by 379,000 for the month and the unemployment rate fell to 6.2%. That compared to expectations of 210,000 new jobs and the unemployment rate to hold steady from the 6.3% rate in January, according to Dow Jones.As rates jumped, tech shares with high valuations got hit again in the premarket, continuing the pattern this week. Tesla and Peloton shares fell declined.The move in futures followed a sharp sell-off on Thursday triggered by Federal Reserve Chair Jerome Powell’s remarks on rising bond yields. The Fed chair said the recent runup caught his attention but he didn’t give any indication of how the central bank would rein it in. Some investors had expected Powell to signal his willingness to adjust the Fed’s asset purchase program.The economic reopening could “create some upward pressure on prices,” Powell said in a Wall Street Journal webinar Thursday. Even if the economy sees “transitory increases in inflation … I expect that we will be patient,” he added.“Equity investors, in our conversations, are really grappling with two things they may not have had to deal with for the last 10 years,” said Tom Lee, Fundstrat’s co-founder head of research. “One is the potential for inflation to actually have to be priced into equities. I think there’s a lot of confusion.”“Then it’s a bond market that seems to be testing the Fed, which kind of scares people,” added Lee, who believes the sell-off this week is a buying opportunity.Tech stocks led the market decline Thursday, especially those with high valuations and small or no profitability. The Nasdaq Composite dropped 2.1% Thursday, bringing its losses this week to 3.6%. The tech-heavy benchmark also turned negative for the year and fell into correction territory, or down 10% from a recent high, on an intraday basis.Tesla shares were off their lows in Friday premarket trading but still down 0.3%.The S&P 500 and the Dow both fell more than 1% Thursday, headed for a losing week. Energy outperformed with a 2.5% gain in the previous session amid a jump in oil prices.“Rates soared once again, which opened the door for more selling of technology stocks,” said Ryan Detrick, chief market strategist at LPL Financial. “The bright side is the economy continues to improve and leadership from financials and energy is something that suggests this isn’t a sell everything moment.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320600626,"gmtCreate":1615086673965,"gmtModify":1704778559721,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320600626","repostId":"2117639609","repostType":4,"repost":{"id":"2117639609","pubTimestamp":1614957600,"share":"https://www.laohu8.com/m/news/2117639609?lang=&edition=full","pubTime":"2021-03-05 23:20","market":"us","language":"en","title":"What's the Outlook for Intuitive Surgical?","url":"https://stock-news.laohu8.com/highlight/detail?id=2117639609","media":"Jason Hawthorne","summary":"Competition is heating up, but the company's market leadership remains unchallenged.","content":"<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, <b>Intuitive</b> <b>Surgical</b> (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"</p><p>After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>The arms of a surgical robot. Image source: Getty Images.</p><p><b>Managing through COVID-19</b></p><p>Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.</p><p>Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.</p><p>Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.</p><p>Although this is definitely a concern, it's a temporary <a href=\"https://laohu8.com/S/AONE\">one</a>. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.</p><p><b>A changing regulatory landscape</b></p><p>In recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.</p><p>One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.</p><p><b>Defending the moat</b></p><p>One of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by <b>Meere</b> back in 2017.</p><p>Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers <b>Medtronic</b> (NYSE:MDT) and <b>Johnson</b> <b>&amp;</b> <b>Johnson</b> (NYSE:JNJ).</p><p>Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.</p><p>Johnson &amp; Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.</p><p>First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to <b>Stryker</b> and <b>Smith</b> <b>&amp;</b> <b>Nephew</b>, not Intuitive.</p><p>Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.</p><p>And third, Johnson &amp; Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.</p><p><b>Clear skies, with a few clouds on the horizon</b></p><p>Despite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.</p><p>As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's the Outlook for Intuitive Surgical?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's the Outlook for Intuitive Surgical?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-05 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/><strong>Jason Hawthorne</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize","relate_stocks":{"ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117639609","content_text":"After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, Intuitive Surgical (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.The arms of a surgical robot. Image source: Getty Images.Managing through COVID-19Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.Although this is definitely a concern, it's a temporary one. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.A changing regulatory landscapeIn recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.Defending the moatOne of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by Meere back in 2017.Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ).Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.Johnson & Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to Stryker and Smith & Nephew, not Intuitive.Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.And third, Johnson & Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.Clear skies, with a few clouds on the horizonDespite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.","news_type":1},"isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320862574,"gmtCreate":1615080904598,"gmtModify":1704778500513,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Makes sense","listText":"Makes sense","text":"Makes sense","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320862574","repostId":"2117201682","repostType":4,"repost":{"id":"2117201682","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1614937800,"share":"https://www.laohu8.com/m/news/2117201682?lang=&edition=full","pubTime":"2021-03-05 17:50","market":"us","language":"en","title":"Buy this dip in Apple, Microsoft and these other tech stocks before they're out of reach, says analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2117201682","media":"Dow Jones","summary":"Critical information for the U.S. trading day.It has been a bad week for technology stocks. The Nasd","content":"<blockquote>Critical information for the U.S. trading day.</blockquote><p>It has been a bad week for technology stocks. The Nasdaq tumbled 2.7% on Wednesday and fell a further 2.1% on Thursday.</p><p>So buy the dip before tech stocks move at least 25% higher this year, says veteran tech analyst Daniel Ives of investment firm Wedbush in our call of the day.</p><p>\"The risk-off trade for tech has been a painful <a href=\"https://laohu8.com/S/AONE\">one</a> for tech investors this week as worries around high valuations, bubble fears, rotation trade, rising yields and a focus on reopening plays take center stage,\" Ives said.</p><p>But, according to Ives, the digital transformation is just getting started and will last a number of years among companies in cloud, cybersecurity, e-commerce and 5G. These subsectors are the life of the tech party, with consumer and enterprise demand catalyzing a \"multiyear growth boom\" ahead, the analyst said.</p><p>Though collaboration-software groups like <a href=\"https://laohu8.com/S/ZM\">Zoom</a> (ZM), Microsoft Teams, Slack <a href=\"https://laohu8.com/S/WORK\">$(WORK)$</a>, and Citrix <a href=\"https://laohu8.com/S/CTXS\">$(CTXS)$</a> will see \"moderating growth\" into 2022, many chief executives have told Wedbush that 30% to 40% of employees could remain working remotely in some form. This will prompt companies to \"rip the Band-Aid off and go aggressive\" with cloud transformations, Ives said.</p><p>Investors should use the current market weakness to ensure that the following companies are in their portfolios, according to Ives: Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, Microsoft <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, digital document specialist DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a>, AI pioneer Nuance <a href=\"https://laohu8.com/S/NUAN\">$(NUAN)$</a>, and cybersecurity groups Zscaler <a href=\"https://laohu8.com/S/ZS\">$(ZS)$</a>, Palo Alto <a href=\"https://laohu8.com/S/PANW\">$(PANW)$</a>, and SailPoint <a href=\"https://laohu8.com/S/SAIL\">$(SAIL)$</a>.</p><p>Across the wider sector, Wedbush predicts that tech stocks will move at least 25% upward in the next year. That will be driven by big names <a href=\"https://laohu8.com/S/FB\">Facebook</a> (FB), Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, Apple, Netflix <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a> and Google parent Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL), as well as cloud and cybersecurity stocks, despite the recent selloff, Ives said.</p><p>More broadly, Ives said that Uber <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> -- \"disruptive tech recovery names\" -- remain Wedbush's favorite \"reopening plays,\" with profitability on the horizon and a massive surge in food delivery.</p><p>And while tech regulation is a long-term risk, \"it still remains a Goldilocks environment for tech stocks with the Biden administration,\" according to Wedbush. Ives sees President Joe Biden as likely to ramp down tensions in the \"Cold Tech War\" brewing between the U.S. and China, as well as encourage cybersecurity initiatives.</p><p>Market bears will come out of hibernation to warn investors that the tech boom and bull rally is over, Ives said. Wedbush believes this is \"a golden opportunity to own the secular tech winners for the next 12 to 18 months at compelling valuations given some of these selloffs.\"</p><p><b>The buzz</b></p><p>The House of Representatives wrapped up the week after police discovered a QAnon-linked militia plot , who was killed during an arrest in May 2020.</p><p>On the economic front , initial jobless claims were the headline figure on Thursday. 745,000 Americans filed for unemployment last week, which was slightly less than expected but an increase from 730,000 the week prior. There were 4.3 million continuing jobless claims in the week of Feb. 20, down from 4.42 million in the week before that, and U.S. factory orders for January rose 2.6%, slightly ahead of the 2.3% expected. Federal Reserve Chair Jerome Powell said that the central bank is paying attention to the recent bond market selloff during a Wall Street Journal webinar.</p><p>SpaceX's Starship -- a prototype for a future Mars mission -- looked like it aced a landing to make founder Elon Musk proud .</p><p>The CEO of Texas' power grid has been fired . The grid suffered a fatal failure in a freezing February that left millions without heat or electricity for days in <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst blackouts in U.S. history.</p><p>The European Medicines Agency, the drug regulator for the European Union, has started a review of the Sputnik V  COVID-19 vaccine developed in Russia.</p><p>The Competition and Markets Authority, the U.K. competition regulator, is investigating Apple  over the terms and conditions governing developers' access to the App Store.</p><p>The online Indian retailer Flipkart, mostly owned by Walmart <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a>, is considering a U.S. listing through merging with a special-purpose acquisition company  that said the company could seek a valuation of at least $35 billion.</p><p><b>The markets</b></p><p>Stocks continued Wednesday's big slide  to move move deeper into the red. European stocks  were mixed but mostly lower while major Asian indexes   tumbled more than 2%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy this dip in Apple, Microsoft and these other tech stocks before they're out of reach, says analyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy this dip in Apple, Microsoft and these other tech stocks before they're out of reach, says analyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-05 17:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>Critical information for the U.S. trading day.</blockquote><p>It has been a bad week for technology stocks. The Nasdaq tumbled 2.7% on Wednesday and fell a further 2.1% on Thursday.</p><p>So buy the dip before tech stocks move at least 25% higher this year, says veteran tech analyst Daniel Ives of investment firm Wedbush in our call of the day.</p><p>\"The risk-off trade for tech has been a painful <a href=\"https://laohu8.com/S/AONE\">one</a> for tech investors this week as worries around high valuations, bubble fears, rotation trade, rising yields and a focus on reopening plays take center stage,\" Ives said.</p><p>But, according to Ives, the digital transformation is just getting started and will last a number of years among companies in cloud, cybersecurity, e-commerce and 5G. These subsectors are the life of the tech party, with consumer and enterprise demand catalyzing a \"multiyear growth boom\" ahead, the analyst said.</p><p>Though collaboration-software groups like <a href=\"https://laohu8.com/S/ZM\">Zoom</a> (ZM), Microsoft Teams, Slack <a href=\"https://laohu8.com/S/WORK\">$(WORK)$</a>, and Citrix <a href=\"https://laohu8.com/S/CTXS\">$(CTXS)$</a> will see \"moderating growth\" into 2022, many chief executives have told Wedbush that 30% to 40% of employees could remain working remotely in some form. This will prompt companies to \"rip the Band-Aid off and go aggressive\" with cloud transformations, Ives said.</p><p>Investors should use the current market weakness to ensure that the following companies are in their portfolios, according to Ives: Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, Microsoft <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, digital document specialist DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a>, AI pioneer Nuance <a href=\"https://laohu8.com/S/NUAN\">$(NUAN)$</a>, and cybersecurity groups Zscaler <a href=\"https://laohu8.com/S/ZS\">$(ZS)$</a>, Palo Alto <a href=\"https://laohu8.com/S/PANW\">$(PANW)$</a>, and SailPoint <a href=\"https://laohu8.com/S/SAIL\">$(SAIL)$</a>.</p><p>Across the wider sector, Wedbush predicts that tech stocks will move at least 25% upward in the next year. That will be driven by big names <a href=\"https://laohu8.com/S/FB\">Facebook</a> (FB), Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, Apple, Netflix <a href=\"https://laohu8.com/S/NFLX\">$(NFLX)$</a> and Google parent Alphabet <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL), as well as cloud and cybersecurity stocks, despite the recent selloff, Ives said.</p><p>More broadly, Ives said that Uber <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> -- \"disruptive tech recovery names\" -- remain Wedbush's favorite \"reopening plays,\" with profitability on the horizon and a massive surge in food delivery.</p><p>And while tech regulation is a long-term risk, \"it still remains a Goldilocks environment for tech stocks with the Biden administration,\" according to Wedbush. Ives sees President Joe Biden as likely to ramp down tensions in the \"Cold Tech War\" brewing between the U.S. and China, as well as encourage cybersecurity initiatives.</p><p>Market bears will come out of hibernation to warn investors that the tech boom and bull rally is over, Ives said. Wedbush believes this is \"a golden opportunity to own the secular tech winners for the next 12 to 18 months at compelling valuations given some of these selloffs.\"</p><p><b>The buzz</b></p><p>The House of Representatives wrapped up the week after police discovered a QAnon-linked militia plot , who was killed during an arrest in May 2020.</p><p>On the economic front , initial jobless claims were the headline figure on Thursday. 745,000 Americans filed for unemployment last week, which was slightly less than expected but an increase from 730,000 the week prior. There were 4.3 million continuing jobless claims in the week of Feb. 20, down from 4.42 million in the week before that, and U.S. factory orders for January rose 2.6%, slightly ahead of the 2.3% expected. Federal Reserve Chair Jerome Powell said that the central bank is paying attention to the recent bond market selloff during a Wall Street Journal webinar.</p><p>SpaceX's Starship -- a prototype for a future Mars mission -- looked like it aced a landing to make founder Elon Musk proud .</p><p>The CEO of Texas' power grid has been fired . The grid suffered a fatal failure in a freezing February that left millions without heat or electricity for days in <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the worst blackouts in U.S. history.</p><p>The European Medicines Agency, the drug regulator for the European Union, has started a review of the Sputnik V  COVID-19 vaccine developed in Russia.</p><p>The Competition and Markets Authority, the U.K. competition regulator, is investigating Apple  over the terms and conditions governing developers' access to the App Store.</p><p>The online Indian retailer Flipkart, mostly owned by Walmart <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a>, is considering a U.S. listing through merging with a special-purpose acquisition company  that said the company could seek a valuation of at least $35 billion.</p><p><b>The markets</b></p><p>Stocks continued Wednesday's big slide  to move move deeper into the red. European stocks  were mixed but mostly lower while major Asian indexes   tumbled more than 2%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","03086":"华夏纳指","09086":"华夏纳指-U"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117201682","content_text":"Critical information for the U.S. trading day.It has been a bad week for technology stocks. The Nasdaq tumbled 2.7% on Wednesday and fell a further 2.1% on Thursday.So buy the dip before tech stocks move at least 25% higher this year, says veteran tech analyst Daniel Ives of investment firm Wedbush in our call of the day.\"The risk-off trade for tech has been a painful one for tech investors this week as worries around high valuations, bubble fears, rotation trade, rising yields and a focus on reopening plays take center stage,\" Ives said.But, according to Ives, the digital transformation is just getting started and will last a number of years among companies in cloud, cybersecurity, e-commerce and 5G. These subsectors are the life of the tech party, with consumer and enterprise demand catalyzing a \"multiyear growth boom\" ahead, the analyst said.Though collaboration-software groups like Zoom (ZM), Microsoft Teams, Slack $(WORK)$, and Citrix $(CTXS)$ will see \"moderating growth\" into 2022, many chief executives have told Wedbush that 30% to 40% of employees could remain working remotely in some form. This will prompt companies to \"rip the Band-Aid off and go aggressive\" with cloud transformations, Ives said.Investors should use the current market weakness to ensure that the following companies are in their portfolios, according to Ives: Apple $(AAPL)$, Microsoft $(MSFT)$, digital document specialist DocuSign $(DOCU)$, AI pioneer Nuance $(NUAN)$, and cybersecurity groups Zscaler $(ZS)$, Palo Alto $(PANW)$, and SailPoint $(SAIL)$.Across the wider sector, Wedbush predicts that tech stocks will move at least 25% upward in the next year. That will be driven by big names Facebook (FB), Amazon $(AMZN)$, Apple, Netflix $(NFLX)$ and Google parent Alphabet $(GOOGL)$(GOOGL), as well as cloud and cybersecurity stocks, despite the recent selloff, Ives said.More broadly, Ives said that Uber $(UBER)$ and Lyft $(LYFT)$ -- \"disruptive tech recovery names\" -- remain Wedbush's favorite \"reopening plays,\" with profitability on the horizon and a massive surge in food delivery.And while tech regulation is a long-term risk, \"it still remains a Goldilocks environment for tech stocks with the Biden administration,\" according to Wedbush. Ives sees President Joe Biden as likely to ramp down tensions in the \"Cold Tech War\" brewing between the U.S. and China, as well as encourage cybersecurity initiatives.Market bears will come out of hibernation to warn investors that the tech boom and bull rally is over, Ives said. Wedbush believes this is \"a golden opportunity to own the secular tech winners for the next 12 to 18 months at compelling valuations given some of these selloffs.\"The buzzThe House of Representatives wrapped up the week after police discovered a QAnon-linked militia plot , who was killed during an arrest in May 2020.On the economic front , initial jobless claims were the headline figure on Thursday. 745,000 Americans filed for unemployment last week, which was slightly less than expected but an increase from 730,000 the week prior. There were 4.3 million continuing jobless claims in the week of Feb. 20, down from 4.42 million in the week before that, and U.S. factory orders for January rose 2.6%, slightly ahead of the 2.3% expected. Federal Reserve Chair Jerome Powell said that the central bank is paying attention to the recent bond market selloff during a Wall Street Journal webinar.SpaceX's Starship -- a prototype for a future Mars mission -- looked like it aced a landing to make founder Elon Musk proud .The CEO of Texas' power grid has been fired . The grid suffered a fatal failure in a freezing February that left millions without heat or electricity for days in one of the worst blackouts in U.S. history.The European Medicines Agency, the drug regulator for the European Union, has started a review of the Sputnik V  COVID-19 vaccine developed in Russia.The Competition and Markets Authority, the U.K. competition regulator, is investigating Apple  over the terms and conditions governing developers' access to the App Store.The online Indian retailer Flipkart, mostly owned by Walmart $(WMT)$, is considering a U.S. listing through merging with a special-purpose acquisition company  that said the company could seek a valuation of at least $35 billion.The marketsStocks continued Wednesday's big slide  to move move deeper into the red. European stocks  were mixed but mostly lower while major Asian indexes   tumbled more than 2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320868688,"gmtCreate":1615080757744,"gmtModify":1704778497238,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Woah","listText":"Woah","text":"Woah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/320868688","repostId":"1172045569","repostType":4,"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320868195,"gmtCreate":1615080746317,"gmtModify":1704778497074,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"They need to catch up to survive","listText":"They need to catch up to survive","text":"They need to catch up to survive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320868195","repostId":"2117638933","repostType":4,"repost":{"id":"2117638933","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1614947300,"share":"https://www.laohu8.com/m/news/2117638933?lang=&edition=full","pubTime":"2021-03-05 20:28","market":"us","language":"en","title":"The Next Tesla May Emerge From This Explosion Of New EV Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2117638933","media":"Investors","summary":"Tesla stock’s huge run fueled demand for stocks like Nio. Now, dozens are vying for attention. Here's an investor guide to the swarm of new EV stocks.","content":"<p>The stunning run of Tesla stock over the past year fueled investor demand for a wave of new EV stocks. The new names represent everything from companies that sell tens of thousands of electric cars a year to startups that have yet to deliver a single vehicle.</p><p>And more EV stocks are coming, if you loosen the meaning of the phrase. Legacy auto giants like <b>General Motors</b> and <b>Ford</b> are transforming into electric-vehicle companies and plan scores of new models. Battery developers and EV charging networks have seen a burst of enthusiasm for their shares as investors bet on a new era of transportation and green energy.</p><p>While EV stocks have pulled back from dizzying highs lately, <a href=\"https://laohu8.com/S/AONE\">one</a> of them may be laying the technological groundwork right now to be the next <b>Tesla</b> or Nio stock.</p><p>But in the near term, investors in EV stocks should buckle up for a bumpy ride.</p><p>\"Nobody should expect anything but more volatility for the next year,\" said Michael Dunne, CEO of the auto consultancy ZoZo Go. \"That's how uncertain the future is with regard to EV startups.\"</p><p>Tesla's 2020 delivery total of nearly 500,000 electric vehicles set a high bar for challengers. Meanwhile, Tesla stock easily remains No. 1 by market cap in the auto industry, with a current value of $582 billion.</p><p><b>List Of New EV Stocks, Startups</b></p><table border=\"0\" width=\"100%\"><tbody><tr><td><b>Company</b></td><td><b>Symbol</b></td><td><b>Country</b></td><td><b>Electric vehicle exposure</b></td></tr><tr><td>Nio</td><td>NIO</td><td>China</td><td>SUVs, sedans</td></tr><tr><td>Xpeng</td><td>XPEV</td><td>China</td><td>SUVs, sedans</td></tr><tr><td>Li Auto</td><td>LI</td><td>China</td><td>SUVs</td></tr><tr><td>Nikola</td><td>NKLA</td><td>U.S.</td><td>Commercial trucks</td></tr><tr><td>Fisker</td><td>FSR</td><td>U.S.</td><td>SUVs</td></tr><tr><td>Canoo</td><td>GOEV</td><td>U.S.</td><td>Cars, minibuses, commercial vehicles</td></tr><tr><td>Lordstown</td><td>RIDE</td><td>U.S.</td><td>Pickup trucks for fleets</td></tr><tr><td>Rivian</td><td>not public yet</td><td>U.S.</td><td>Pickup trucks, SUVs, delivery vans</td></tr><tr><td>Faraday Future</td><td>PSAC/FFIE</td><td>U.S.</td><td>Luxury sedans</td></tr><tr><td>Lucid</td><td>CCIV/LCID</td><td>U.S.</td><td>Luxury sedans</td></tr><tr><td>Xos Trucks</td><td>NGAC/XOS</td><td>U.S.</td><td>Commercial trucks, batteries</td></tr><tr><td>QuantumScape</td><td>QS</td><td>U.S.</td><td>Batteries</td></tr><tr><td>Romeo Power</td><td>RMO</td><td>U.S.</td><td>Batteries</td></tr><tr><td>Hyliion</td><td>HYLN</td><td>U.S.</td><td>Commercial truck powertrains</td></tr><tr><td><a href=\"https://laohu8.com/S/BLNK\">Blink Charging</a></td><td>BLNK</td><td>U.S.</td><td>EV charging stations</td></tr><tr><td>ChargePoint</td><td>CHPT</td><td>U.S.</td><td>EV charging stations</td></tr><tr><td>EVgo</td><td>CLII/EVGO</td><td>U.S.</td><td>EV charging stations</td></tr></tbody></table><hr><p><b>Nio Stock Eyes AI Edge Over EV Rivals</b></p><p>Many EV startups lack any real sales or production. Not so for several Chinese companies that went public in the U.S. between 2018 and 2020 and are seeing growth soar.</p><p>One of them is Nio stock, which took off in March 2020. <b>Nio</b>'s combination of innovation and brand awareness is seen helping it stand out from rivals like <b>Xpeng Motors</b> and <b>Li Auto</b>.</p><p>Sales of Nio's premium electric SUVs climbed 113% in 2020 to 43,728. The EC6 crossover, which only went on sale in September, is already Nio's top seller. The EC6 now faces competition from Tesla's Model Y and soon <b>Volkswagen</b>'s ID.4, which launches in China in late March.</p><p>But Nio moved early and quickly to put artificial intelligence in its cars, analysts say. And a new Nio EV, the sleek ET7 sedan unveiled in January, is supposed to make the leap from advanced driver-assist systems (ADAS) to autonomous driving.</p><p>\"Nio pioneered this clean-sheet approach, where you're essentially building the software from the ground up, whether it's for entertainment, for AI, or for ADAS,\" said Deutsche Bank analyst Edison Yu.</p><p>But its biggest innovations go beyond the car itself. In 2020, Nio broke the norm with an option to buy electric cars without batteries, instead letting users rent the battery for a monthly fee.</p><p>Nio stock has come off highs reached in early January and is back below the 50-day line for the first time in nearly a year. Nio's mixed Q4 financial results and a warning that the global chip shortage will dent production sent shares down further. <i>(Is Nio stock a buy as the chip shortage weighs on its outlook?)</i></p><p><b>Other China EV Stocks To Watch</b></p><p>But Nio's rivals are preparing for more intense competition. Xpeng and Li Auto raised billions of dollars in late 2020&nbsp;as they joined an arms race for capital vs. Nio and Tesla.</p><p>Xpeng sold 27,041 electric cars last year, up 112%. Xpeng sells the P7 sedan and G3 compact SUV. Like Tesla, Xpeng is expanding a network of supercharging stations across China. It's also even further along on autonomous EV technology, Yu says, though it lacks Nio's brand power.</p><p>After volume production began in late 2019, Li Auto delivered 32,624 units of its Li One electric SUV for all of 2020. In December, Goldman Sachs analysts said Li Auto was differentiating itself by \"envisioning and creating compelling EV consumer experiences — and showing a willingness to take on the risk of unconventional technologies and act innovatively.\"</p><p>While Tesla stock and Nio stock grab the attention among EV investors, the leader by sales volume in China is the less-well-known <b>BYD</b>. It sold 130,968 battery electric vehicles last year, down 11%, despite launching the Han sedan and Tang SUV. That number doesn't include the company's plug-in hybrids and other \"new energy vehicles.\" BYD has the distinction of counting Warren Buffett's <b>Berkshire Hathaway</b> as an investor.</p><p>Like Nio stock, Xpeng and Li Auto have come well off their highs along with other growth stocks.&nbsp;Meanwhile, GM stock, Ford stock and VW are doing better in 2021, though the new EV stocks are crushing the old guard from the start of 2020. In fact, Nio stock is up more than 1,700% from last year's low, while GM is up about 260% in the same period.</p><p><b>Early Days For U.S. EV Startups</b></p><p>Most of the U.S. EV startups that came public recently, or are about to go public, have done so via special purpose acquisition companies. But merging with a SPAC allows for less disclosure than a traditional IPO, meaning more potential risk for investors.</p><p>Unlike the Chinese EV stocks, the U.S. newcomers are still developing their vehicles. So it's too soon to tell which could emerge as a disrupter, says Deutsche Bank analyst Emmanuel Rosner.</p><p>\"They are mostly talking about a business model rather than actually producing vehicles,\" he added.</p><p>And yet Wall Street can't get enough of EV stocks. They include <b>Nikola</b>, <b>Fisker</b>, <b>Canoo</b> and <b>Lordstown</b>. Others, like Rivian, aren't public yet, while Lucid, Faraday Future, and Xos Trucks will debut after their blank-check deals close. In fact, Lucid's record blank-check deal values the company at $24 billion, while delivery of its first EV, the luxury Lucid Air sedan, won't happen until later this year.</p><p>For now, some of the EV stocks are aiming for niche markets rather than taking on the world.</p><p>Faraday's FF 91, which will cost $150,000 to $200,000, touts 11 screens and a \"spa mode\" where lights dim and fully reclined seats massage passengers. Meanwhile, Canoo specializes in cars, minibuses and commercial vehicles for rental and sharing services.</p><p>\"It's less about becoming the next Tesla and more about exploiting what they view as underserved markets,\" Rosner said.</p><p>But Faraday plans a commercial EV for last-mile deliveries in 2023 and two mass-market EVs by 2024. And Tesla started also at the high end of the EV market with its Roadster, which went on sale in 2006 for more than $100,000.</p><p>Most of the new EV stocks or shares of the shell company SPACs are slumping after initial spikes. But Fisker stock, after reporting a jump in reservations, has hit new highs.</p><p><b>Beyond Tesla Stock: Intense Competition In Electric Trucks</b></p><p>Meanwhile, other startups are making electric pickup trucks and SUVs, targeting the most lucrative segment of the auto market, where Tesla, GM and other giant auto companies are making moves.</p><p>Dunne says Rivian, which is expected to go public this year, is best poised to challenge established automakers.</p><p>\"Rivian is a quality organization top to bottom, with powerful backers, and an understanding from a design perspective of who their customer is — premium customers looking for off-road experiences with their SUVs and their trucks,\" he said.</p><p>Its R1T pickup truck is due to arrive in June, bankrolled by $8 billion in investments from the likes of <b>Amazon</b>, Fidelity and even Ford. A second EV, the R1S SUV, arrives in August.</p><p>Its technology may be key to gaining an edge over Tesla's Cybertruck and GM's electric Hummer truck. Rivian touts batteries that can endure the hottest and coldest places, deliver 400 miles on a charge, drive to a wading depth of three feet and provide towing capacity of up to 11,000 pounds. And Rivian's R1T, packed with 28 cameras and sensors, could be the first electric truck to offer highly autonomous driving on U.S. highways.</p><p>Fisker, meanwhile, will start production of its Ocean electric SUV in late 2022. It could get a technology boost from Apple supplier Foxconn, which is teaming up with Fisker to develop another EV.</p><p><b>Commercial EV Stocks</b></p><p>A hot subset of the EV market is for commercial vehicles, and investors will find some of the same names that play in other segments. Some stocks to watch include GM and Ford.</p><p>Nikola had planned its own electric pickup but lost GM as a manufacturing partner. Still, Nikola's Tre battery-electric semi-truck will begin deliveries&nbsp;in Q4.</p><p>That highlights the opportunity other EV stocks have in the market for commercial vehicles. Selling to large businesses may be the fastest way to recoup the steep costs of developing EVs.</p><p>Lordstown aims to start production of its Endurance electric pickup, which targets fleet operators, in September.</p><p>Electric cargo and shuttle vans for commercial customers also loom large. <b>Workhorse Group</b> and <b>Lightning eMotors</b> are developing electric vans.</p><p>Rivian is building delivery vans for Amazon that will launch this year. And Canoo's delivery van models will go into limited production in 2022.</p><p>But the upstarts are entering a competitive market. General Motors and Ford have new, all-electric delivery vans hitting the road in late 2021.</p><p><b>Legacy Automakers Becoming EV Stocks</b></p><p>Global auto companies like GM, Ford and Volkswagen are about to let loose a staggering electric-vehicle onslaught.</p><p>VW has a five-year spending plan of $86 billion, with plans for 70 fully electric vehicles by 2030. Ford more than doubled its investments in electric and autonomous vehicles to $29 billion through 2025. Its goal is to launch 16 fully electric cars by 2022, and sales of the new Mustang Mach-E have been strong so far.</p><p>GM plans to spend $27 billion, up from a prior target of $20 billion, and aims to launch 30 new EVs around the world by 2025 across its luxury and mass-market brands.</p><p>GM's transformation has drawn particular attention. \"We believe investors should prepare for a profound narrative change at GM put into action in 2021,\" <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> analyst Adam Jonas wrote in a January note.</p><p>That month, GM revealed a new and potentially disruptive EV business, called BrightDrop, focused on the delivery and logistics market.</p><p>But the linchpin of its EV strategy is the Ultium battery technology, which GM says will support a range of 450 miles on a single charge while reducing costs and weight. A next-generation Ultium platform is already in the works to extend the range to 600 miles.</p><p>\"We will seize every opportunity to drive growth, expand our markets and enter new ones,\" CEO Mary Barra said Feb. 10. \"Our Ultium platform is core to these initiatives. It is the foundation for our upcoming global family of EVs.\"</p><p><b>EV Battery And Charging Companies</b></p><p>Companies making vehicles aren't the only EV stocks for investors to watch. Other companies make car batteries and car charging stations. Among them are new IPO stocks <b>Blink Charging</b> and <b>QuantumScape</b> in 2020. <b>ChargePoint</b> debuted March 1. Rival EVgo will go public via blank-check firm <b><a href=\"https://laohu8.com/S/CLII.U\">Climate Change Crisis Real Impact I Acquisition Corp.</a></b> in Q2 under the ticker EVGO.</p><p>Meanwhile, <b>Hyliion</b> will start shipping its electric powertrain for big-rig trucks, with a claimed range of 1,000 miles. It's also developing powertrains that can be compatible with renewable natural gas and hydrogen fuel cells.</p><p><b>Romeo Power</b> makes battery packs for commercial EV fleets. Other names are Enovix and Microvast, which are coming public via SPAC mergers.</p><p>QuantumScape appears to have achieved a major breakthrough in developing solid-state lithium metal batteries. The batteries promise to be safer and cheaper, have a longer life span, charge faster and have more energy density than existing lithium ion batteries.</p><p>On Feb. 16, the Bill Gates- and Volkswagen-backed startup revealed it can produce multilayered battery cells. Its four-layer battery is still short of the 12 or so needed to be commercially viable. But the company is confident enough in its ability to make progress that it decided to build a \"pre-pilot\" production facility to make \"enough batteries for hundreds of long-range battery electric test vehicles per year\" by 2023.</p><p>\"The company has shown its battery cell can charge up to 80% of capacity in 15 minutes, which would be a 'game changer' if this scales at mass volumes,\" Wedbush analyst Dan Ives wrote in a recent note.</p><p><b>It's Not Just Tesla Stock</b></p><p>For now, Tesla stock is 30% below its intraday record, has given back all its gains so far this year, and is below the price when it debuted on the S&amp;P 500. Its recent dive below the 50-day line was a sell signal, according to IBD Leaderboard.</p><p>But Ives, a prominent Tesla stock bull, said in a March 4 note that \"the EV party and transformation is just beginning,\" adding that a \"green tidal wave\" is on the horizon as EV adoption speeds up.</p><p>He also predicted the electric-vehicle industry could balloon to a $5 trillion market over the next decade. That's up from about $250 billion in 2020.</p><p>And that growth forecast also applies to the legacy auto giants, Ives wrote, pointing to the likes of GM and Ford \"jumping into the deep end of the pool on EVs.\"</p><p>In an interview Dec. 29, Ives suggested it's not just going to be Tesla's world. \"It's an ocean of opportunities,\" Ives told IBD. \"There's room for more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> boat.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Next Tesla May Emerge From This Explosion Of New EV Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Next Tesla May Emerge From This Explosion Of New EV Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-03-05 20:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The stunning run of Tesla stock over the past year fueled investor demand for a wave of new EV stocks. The new names represent everything from companies that sell tens of thousands of electric cars a year to startups that have yet to deliver a single vehicle.</p><p>And more EV stocks are coming, if you loosen the meaning of the phrase. Legacy auto giants like <b>General Motors</b> and <b>Ford</b> are transforming into electric-vehicle companies and plan scores of new models. Battery developers and EV charging networks have seen a burst of enthusiasm for their shares as investors bet on a new era of transportation and green energy.</p><p>While EV stocks have pulled back from dizzying highs lately, <a href=\"https://laohu8.com/S/AONE\">one</a> of them may be laying the technological groundwork right now to be the next <b>Tesla</b> or Nio stock.</p><p>But in the near term, investors in EV stocks should buckle up for a bumpy ride.</p><p>\"Nobody should expect anything but more volatility for the next year,\" said Michael Dunne, CEO of the auto consultancy ZoZo Go. \"That's how uncertain the future is with regard to EV startups.\"</p><p>Tesla's 2020 delivery total of nearly 500,000 electric vehicles set a high bar for challengers. Meanwhile, Tesla stock easily remains No. 1 by market cap in the auto industry, with a current value of $582 billion.</p><p><b>List Of New EV Stocks, Startups</b></p><table border=\"0\" width=\"100%\"><tbody><tr><td><b>Company</b></td><td><b>Symbol</b></td><td><b>Country</b></td><td><b>Electric vehicle exposure</b></td></tr><tr><td>Nio</td><td>NIO</td><td>China</td><td>SUVs, sedans</td></tr><tr><td>Xpeng</td><td>XPEV</td><td>China</td><td>SUVs, sedans</td></tr><tr><td>Li Auto</td><td>LI</td><td>China</td><td>SUVs</td></tr><tr><td>Nikola</td><td>NKLA</td><td>U.S.</td><td>Commercial trucks</td></tr><tr><td>Fisker</td><td>FSR</td><td>U.S.</td><td>SUVs</td></tr><tr><td>Canoo</td><td>GOEV</td><td>U.S.</td><td>Cars, minibuses, commercial vehicles</td></tr><tr><td>Lordstown</td><td>RIDE</td><td>U.S.</td><td>Pickup trucks for fleets</td></tr><tr><td>Rivian</td><td>not public yet</td><td>U.S.</td><td>Pickup trucks, SUVs, delivery vans</td></tr><tr><td>Faraday Future</td><td>PSAC/FFIE</td><td>U.S.</td><td>Luxury sedans</td></tr><tr><td>Lucid</td><td>CCIV/LCID</td><td>U.S.</td><td>Luxury sedans</td></tr><tr><td>Xos Trucks</td><td>NGAC/XOS</td><td>U.S.</td><td>Commercial trucks, batteries</td></tr><tr><td>QuantumScape</td><td>QS</td><td>U.S.</td><td>Batteries</td></tr><tr><td>Romeo Power</td><td>RMO</td><td>U.S.</td><td>Batteries</td></tr><tr><td>Hyliion</td><td>HYLN</td><td>U.S.</td><td>Commercial truck powertrains</td></tr><tr><td><a href=\"https://laohu8.com/S/BLNK\">Blink Charging</a></td><td>BLNK</td><td>U.S.</td><td>EV charging stations</td></tr><tr><td>ChargePoint</td><td>CHPT</td><td>U.S.</td><td>EV charging stations</td></tr><tr><td>EVgo</td><td>CLII/EVGO</td><td>U.S.</td><td>EV charging stations</td></tr></tbody></table><hr><p><b>Nio Stock Eyes AI Edge Over EV Rivals</b></p><p>Many EV startups lack any real sales or production. Not so for several Chinese companies that went public in the U.S. between 2018 and 2020 and are seeing growth soar.</p><p>One of them is Nio stock, which took off in March 2020. <b>Nio</b>'s combination of innovation and brand awareness is seen helping it stand out from rivals like <b>Xpeng Motors</b> and <b>Li Auto</b>.</p><p>Sales of Nio's premium electric SUVs climbed 113% in 2020 to 43,728. The EC6 crossover, which only went on sale in September, is already Nio's top seller. The EC6 now faces competition from Tesla's Model Y and soon <b>Volkswagen</b>'s ID.4, which launches in China in late March.</p><p>But Nio moved early and quickly to put artificial intelligence in its cars, analysts say. And a new Nio EV, the sleek ET7 sedan unveiled in January, is supposed to make the leap from advanced driver-assist systems (ADAS) to autonomous driving.</p><p>\"Nio pioneered this clean-sheet approach, where you're essentially building the software from the ground up, whether it's for entertainment, for AI, or for ADAS,\" said Deutsche Bank analyst Edison Yu.</p><p>But its biggest innovations go beyond the car itself. In 2020, Nio broke the norm with an option to buy electric cars without batteries, instead letting users rent the battery for a monthly fee.</p><p>Nio stock has come off highs reached in early January and is back below the 50-day line for the first time in nearly a year. Nio's mixed Q4 financial results and a warning that the global chip shortage will dent production sent shares down further. <i>(Is Nio stock a buy as the chip shortage weighs on its outlook?)</i></p><p><b>Other China EV Stocks To Watch</b></p><p>But Nio's rivals are preparing for more intense competition. Xpeng and Li Auto raised billions of dollars in late 2020&nbsp;as they joined an arms race for capital vs. Nio and Tesla.</p><p>Xpeng sold 27,041 electric cars last year, up 112%. Xpeng sells the P7 sedan and G3 compact SUV. Like Tesla, Xpeng is expanding a network of supercharging stations across China. It's also even further along on autonomous EV technology, Yu says, though it lacks Nio's brand power.</p><p>After volume production began in late 2019, Li Auto delivered 32,624 units of its Li One electric SUV for all of 2020. In December, Goldman Sachs analysts said Li Auto was differentiating itself by \"envisioning and creating compelling EV consumer experiences — and showing a willingness to take on the risk of unconventional technologies and act innovatively.\"</p><p>While Tesla stock and Nio stock grab the attention among EV investors, the leader by sales volume in China is the less-well-known <b>BYD</b>. It sold 130,968 battery electric vehicles last year, down 11%, despite launching the Han sedan and Tang SUV. That number doesn't include the company's plug-in hybrids and other \"new energy vehicles.\" BYD has the distinction of counting Warren Buffett's <b>Berkshire Hathaway</b> as an investor.</p><p>Like Nio stock, Xpeng and Li Auto have come well off their highs along with other growth stocks.&nbsp;Meanwhile, GM stock, Ford stock and VW are doing better in 2021, though the new EV stocks are crushing the old guard from the start of 2020. In fact, Nio stock is up more than 1,700% from last year's low, while GM is up about 260% in the same period.</p><p><b>Early Days For U.S. EV Startups</b></p><p>Most of the U.S. EV startups that came public recently, or are about to go public, have done so via special purpose acquisition companies. But merging with a SPAC allows for less disclosure than a traditional IPO, meaning more potential risk for investors.</p><p>Unlike the Chinese EV stocks, the U.S. newcomers are still developing their vehicles. So it's too soon to tell which could emerge as a disrupter, says Deutsche Bank analyst Emmanuel Rosner.</p><p>\"They are mostly talking about a business model rather than actually producing vehicles,\" he added.</p><p>And yet Wall Street can't get enough of EV stocks. They include <b>Nikola</b>, <b>Fisker</b>, <b>Canoo</b> and <b>Lordstown</b>. Others, like Rivian, aren't public yet, while Lucid, Faraday Future, and Xos Trucks will debut after their blank-check deals close. In fact, Lucid's record blank-check deal values the company at $24 billion, while delivery of its first EV, the luxury Lucid Air sedan, won't happen until later this year.</p><p>For now, some of the EV stocks are aiming for niche markets rather than taking on the world.</p><p>Faraday's FF 91, which will cost $150,000 to $200,000, touts 11 screens and a \"spa mode\" where lights dim and fully reclined seats massage passengers. Meanwhile, Canoo specializes in cars, minibuses and commercial vehicles for rental and sharing services.</p><p>\"It's less about becoming the next Tesla and more about exploiting what they view as underserved markets,\" Rosner said.</p><p>But Faraday plans a commercial EV for last-mile deliveries in 2023 and two mass-market EVs by 2024. And Tesla started also at the high end of the EV market with its Roadster, which went on sale in 2006 for more than $100,000.</p><p>Most of the new EV stocks or shares of the shell company SPACs are slumping after initial spikes. But Fisker stock, after reporting a jump in reservations, has hit new highs.</p><p><b>Beyond Tesla Stock: Intense Competition In Electric Trucks</b></p><p>Meanwhile, other startups are making electric pickup trucks and SUVs, targeting the most lucrative segment of the auto market, where Tesla, GM and other giant auto companies are making moves.</p><p>Dunne says Rivian, which is expected to go public this year, is best poised to challenge established automakers.</p><p>\"Rivian is a quality organization top to bottom, with powerful backers, and an understanding from a design perspective of who their customer is — premium customers looking for off-road experiences with their SUVs and their trucks,\" he said.</p><p>Its R1T pickup truck is due to arrive in June, bankrolled by $8 billion in investments from the likes of <b>Amazon</b>, Fidelity and even Ford. A second EV, the R1S SUV, arrives in August.</p><p>Its technology may be key to gaining an edge over Tesla's Cybertruck and GM's electric Hummer truck. Rivian touts batteries that can endure the hottest and coldest places, deliver 400 miles on a charge, drive to a wading depth of three feet and provide towing capacity of up to 11,000 pounds. And Rivian's R1T, packed with 28 cameras and sensors, could be the first electric truck to offer highly autonomous driving on U.S. highways.</p><p>Fisker, meanwhile, will start production of its Ocean electric SUV in late 2022. It could get a technology boost from Apple supplier Foxconn, which is teaming up with Fisker to develop another EV.</p><p><b>Commercial EV Stocks</b></p><p>A hot subset of the EV market is for commercial vehicles, and investors will find some of the same names that play in other segments. Some stocks to watch include GM and Ford.</p><p>Nikola had planned its own electric pickup but lost GM as a manufacturing partner. Still, Nikola's Tre battery-electric semi-truck will begin deliveries&nbsp;in Q4.</p><p>That highlights the opportunity other EV stocks have in the market for commercial vehicles. Selling to large businesses may be the fastest way to recoup the steep costs of developing EVs.</p><p>Lordstown aims to start production of its Endurance electric pickup, which targets fleet operators, in September.</p><p>Electric cargo and shuttle vans for commercial customers also loom large. <b>Workhorse Group</b> and <b>Lightning eMotors</b> are developing electric vans.</p><p>Rivian is building delivery vans for Amazon that will launch this year. And Canoo's delivery van models will go into limited production in 2022.</p><p>But the upstarts are entering a competitive market. General Motors and Ford have new, all-electric delivery vans hitting the road in late 2021.</p><p><b>Legacy Automakers Becoming EV Stocks</b></p><p>Global auto companies like GM, Ford and Volkswagen are about to let loose a staggering electric-vehicle onslaught.</p><p>VW has a five-year spending plan of $86 billion, with plans for 70 fully electric vehicles by 2030. Ford more than doubled its investments in electric and autonomous vehicles to $29 billion through 2025. Its goal is to launch 16 fully electric cars by 2022, and sales of the new Mustang Mach-E have been strong so far.</p><p>GM plans to spend $27 billion, up from a prior target of $20 billion, and aims to launch 30 new EVs around the world by 2025 across its luxury and mass-market brands.</p><p>GM's transformation has drawn particular attention. \"We believe investors should prepare for a profound narrative change at GM put into action in 2021,\" <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> analyst Adam Jonas wrote in a January note.</p><p>That month, GM revealed a new and potentially disruptive EV business, called BrightDrop, focused on the delivery and logistics market.</p><p>But the linchpin of its EV strategy is the Ultium battery technology, which GM says will support a range of 450 miles on a single charge while reducing costs and weight. A next-generation Ultium platform is already in the works to extend the range to 600 miles.</p><p>\"We will seize every opportunity to drive growth, expand our markets and enter new ones,\" CEO Mary Barra said Feb. 10. \"Our Ultium platform is core to these initiatives. It is the foundation for our upcoming global family of EVs.\"</p><p><b>EV Battery And Charging Companies</b></p><p>Companies making vehicles aren't the only EV stocks for investors to watch. Other companies make car batteries and car charging stations. Among them are new IPO stocks <b>Blink Charging</b> and <b>QuantumScape</b> in 2020. <b>ChargePoint</b> debuted March 1. Rival EVgo will go public via blank-check firm <b><a href=\"https://laohu8.com/S/CLII.U\">Climate Change Crisis Real Impact I Acquisition Corp.</a></b> in Q2 under the ticker EVGO.</p><p>Meanwhile, <b>Hyliion</b> will start shipping its electric powertrain for big-rig trucks, with a claimed range of 1,000 miles. It's also developing powertrains that can be compatible with renewable natural gas and hydrogen fuel cells.</p><p><b>Romeo Power</b> makes battery packs for commercial EV fleets. Other names are Enovix and Microvast, which are coming public via SPAC mergers.</p><p>QuantumScape appears to have achieved a major breakthrough in developing solid-state lithium metal batteries. The batteries promise to be safer and cheaper, have a longer life span, charge faster and have more energy density than existing lithium ion batteries.</p><p>On Feb. 16, the Bill Gates- and Volkswagen-backed startup revealed it can produce multilayered battery cells. Its four-layer battery is still short of the 12 or so needed to be commercially viable. But the company is confident enough in its ability to make progress that it decided to build a \"pre-pilot\" production facility to make \"enough batteries for hundreds of long-range battery electric test vehicles per year\" by 2023.</p><p>\"The company has shown its battery cell can charge up to 80% of capacity in 15 minutes, which would be a 'game changer' if this scales at mass volumes,\" Wedbush analyst Dan Ives wrote in a recent note.</p><p><b>It's Not Just Tesla Stock</b></p><p>For now, Tesla stock is 30% below its intraday record, has given back all its gains so far this year, and is below the price when it debuted on the S&amp;P 500. Its recent dive below the 50-day line was a sell signal, according to IBD Leaderboard.</p><p>But Ives, a prominent Tesla stock bull, said in a March 4 note that \"the EV party and transformation is just beginning,\" adding that a \"green tidal wave\" is on the horizon as EV adoption speeds up.</p><p>He also predicted the electric-vehicle industry could balloon to a $5 trillion market over the next decade. That's up from about $250 billion in 2020.</p><p>And that growth forecast also applies to the legacy auto giants, Ives wrote, pointing to the likes of GM and Ford \"jumping into the deep end of the pool on EVs.\"</p><p>In an interview Dec. 29, Ives suggested it's not just going to be Tesla's world. \"It's an ocean of opportunities,\" Ives told IBD. \"There's room for more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> boat.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117638933","content_text":"The stunning run of Tesla stock over the past year fueled investor demand for a wave of new EV stocks. The new names represent everything from companies that sell tens of thousands of electric cars a year to startups that have yet to deliver a single vehicle.And more EV stocks are coming, if you loosen the meaning of the phrase. Legacy auto giants like General Motors and Ford are transforming into electric-vehicle companies and plan scores of new models. Battery developers and EV charging networks have seen a burst of enthusiasm for their shares as investors bet on a new era of transportation and green energy.While EV stocks have pulled back from dizzying highs lately, one of them may be laying the technological groundwork right now to be the next Tesla or Nio stock.But in the near term, investors in EV stocks should buckle up for a bumpy ride.\"Nobody should expect anything but more volatility for the next year,\" said Michael Dunne, CEO of the auto consultancy ZoZo Go. \"That's how uncertain the future is with regard to EV startups.\"Tesla's 2020 delivery total of nearly 500,000 electric vehicles set a high bar for challengers. Meanwhile, Tesla stock easily remains No. 1 by market cap in the auto industry, with a current value of $582 billion.List Of New EV Stocks, StartupsCompanySymbolCountryElectric vehicle exposureNioNIOChinaSUVs, sedansXpengXPEVChinaSUVs, sedansLi AutoLIChinaSUVsNikolaNKLAU.S.Commercial trucksFiskerFSRU.S.SUVsCanooGOEVU.S.Cars, minibuses, commercial vehiclesLordstownRIDEU.S.Pickup trucks for fleetsRiviannot public yetU.S.Pickup trucks, SUVs, delivery vansFaraday FuturePSAC/FFIEU.S.Luxury sedansLucidCCIV/LCIDU.S.Luxury sedansXos TrucksNGAC/XOSU.S.Commercial trucks, batteriesQuantumScapeQSU.S.BatteriesRomeo PowerRMOU.S.BatteriesHyliionHYLNU.S.Commercial truck powertrainsBlink ChargingBLNKU.S.EV charging stationsChargePointCHPTU.S.EV charging stationsEVgoCLII/EVGOU.S.EV charging stationsNio Stock Eyes AI Edge Over EV RivalsMany EV startups lack any real sales or production. Not so for several Chinese companies that went public in the U.S. between 2018 and 2020 and are seeing growth soar.One of them is Nio stock, which took off in March 2020. Nio's combination of innovation and brand awareness is seen helping it stand out from rivals like Xpeng Motors and Li Auto.Sales of Nio's premium electric SUVs climbed 113% in 2020 to 43,728. The EC6 crossover, which only went on sale in September, is already Nio's top seller. The EC6 now faces competition from Tesla's Model Y and soon Volkswagen's ID.4, which launches in China in late March.But Nio moved early and quickly to put artificial intelligence in its cars, analysts say. And a new Nio EV, the sleek ET7 sedan unveiled in January, is supposed to make the leap from advanced driver-assist systems (ADAS) to autonomous driving.\"Nio pioneered this clean-sheet approach, where you're essentially building the software from the ground up, whether it's for entertainment, for AI, or for ADAS,\" said Deutsche Bank analyst Edison Yu.But its biggest innovations go beyond the car itself. In 2020, Nio broke the norm with an option to buy electric cars without batteries, instead letting users rent the battery for a monthly fee.Nio stock has come off highs reached in early January and is back below the 50-day line for the first time in nearly a year. Nio's mixed Q4 financial results and a warning that the global chip shortage will dent production sent shares down further. (Is Nio stock a buy as the chip shortage weighs on its outlook?)Other China EV Stocks To WatchBut Nio's rivals are preparing for more intense competition. Xpeng and Li Auto raised billions of dollars in late 2020 as they joined an arms race for capital vs. Nio and Tesla.Xpeng sold 27,041 electric cars last year, up 112%. Xpeng sells the P7 sedan and G3 compact SUV. Like Tesla, Xpeng is expanding a network of supercharging stations across China. It's also even further along on autonomous EV technology, Yu says, though it lacks Nio's brand power.After volume production began in late 2019, Li Auto delivered 32,624 units of its Li One electric SUV for all of 2020. In December, Goldman Sachs analysts said Li Auto was differentiating itself by \"envisioning and creating compelling EV consumer experiences — and showing a willingness to take on the risk of unconventional technologies and act innovatively.\"While Tesla stock and Nio stock grab the attention among EV investors, the leader by sales volume in China is the less-well-known BYD. It sold 130,968 battery electric vehicles last year, down 11%, despite launching the Han sedan and Tang SUV. That number doesn't include the company's plug-in hybrids and other \"new energy vehicles.\" BYD has the distinction of counting Warren Buffett's Berkshire Hathaway as an investor.Like Nio stock, Xpeng and Li Auto have come well off their highs along with other growth stocks. Meanwhile, GM stock, Ford stock and VW are doing better in 2021, though the new EV stocks are crushing the old guard from the start of 2020. In fact, Nio stock is up more than 1,700% from last year's low, while GM is up about 260% in the same period.Early Days For U.S. EV StartupsMost of the U.S. EV startups that came public recently, or are about to go public, have done so via special purpose acquisition companies. But merging with a SPAC allows for less disclosure than a traditional IPO, meaning more potential risk for investors.Unlike the Chinese EV stocks, the U.S. newcomers are still developing their vehicles. So it's too soon to tell which could emerge as a disrupter, says Deutsche Bank analyst Emmanuel Rosner.\"They are mostly talking about a business model rather than actually producing vehicles,\" he added.And yet Wall Street can't get enough of EV stocks. They include Nikola, Fisker, Canoo and Lordstown. Others, like Rivian, aren't public yet, while Lucid, Faraday Future, and Xos Trucks will debut after their blank-check deals close. In fact, Lucid's record blank-check deal values the company at $24 billion, while delivery of its first EV, the luxury Lucid Air sedan, won't happen until later this year.For now, some of the EV stocks are aiming for niche markets rather than taking on the world.Faraday's FF 91, which will cost $150,000 to $200,000, touts 11 screens and a \"spa mode\" where lights dim and fully reclined seats massage passengers. Meanwhile, Canoo specializes in cars, minibuses and commercial vehicles for rental and sharing services.\"It's less about becoming the next Tesla and more about exploiting what they view as underserved markets,\" Rosner said.But Faraday plans a commercial EV for last-mile deliveries in 2023 and two mass-market EVs by 2024. And Tesla started also at the high end of the EV market with its Roadster, which went on sale in 2006 for more than $100,000.Most of the new EV stocks or shares of the shell company SPACs are slumping after initial spikes. But Fisker stock, after reporting a jump in reservations, has hit new highs.Beyond Tesla Stock: Intense Competition In Electric TrucksMeanwhile, other startups are making electric pickup trucks and SUVs, targeting the most lucrative segment of the auto market, where Tesla, GM and other giant auto companies are making moves.Dunne says Rivian, which is expected to go public this year, is best poised to challenge established automakers.\"Rivian is a quality organization top to bottom, with powerful backers, and an understanding from a design perspective of who their customer is — premium customers looking for off-road experiences with their SUVs and their trucks,\" he said.Its R1T pickup truck is due to arrive in June, bankrolled by $8 billion in investments from the likes of Amazon, Fidelity and even Ford. A second EV, the R1S SUV, arrives in August.Its technology may be key to gaining an edge over Tesla's Cybertruck and GM's electric Hummer truck. Rivian touts batteries that can endure the hottest and coldest places, deliver 400 miles on a charge, drive to a wading depth of three feet and provide towing capacity of up to 11,000 pounds. And Rivian's R1T, packed with 28 cameras and sensors, could be the first electric truck to offer highly autonomous driving on U.S. highways.Fisker, meanwhile, will start production of its Ocean electric SUV in late 2022. It could get a technology boost from Apple supplier Foxconn, which is teaming up with Fisker to develop another EV.Commercial EV StocksA hot subset of the EV market is for commercial vehicles, and investors will find some of the same names that play in other segments. Some stocks to watch include GM and Ford.Nikola had planned its own electric pickup but lost GM as a manufacturing partner. Still, Nikola's Tre battery-electric semi-truck will begin deliveries in Q4.That highlights the opportunity other EV stocks have in the market for commercial vehicles. Selling to large businesses may be the fastest way to recoup the steep costs of developing EVs.Lordstown aims to start production of its Endurance electric pickup, which targets fleet operators, in September.Electric cargo and shuttle vans for commercial customers also loom large. Workhorse Group and Lightning eMotors are developing electric vans.Rivian is building delivery vans for Amazon that will launch this year. And Canoo's delivery van models will go into limited production in 2022.But the upstarts are entering a competitive market. General Motors and Ford have new, all-electric delivery vans hitting the road in late 2021.Legacy Automakers Becoming EV StocksGlobal auto companies like GM, Ford and Volkswagen are about to let loose a staggering electric-vehicle onslaught.VW has a five-year spending plan of $86 billion, with plans for 70 fully electric vehicles by 2030. Ford more than doubled its investments in electric and autonomous vehicles to $29 billion through 2025. Its goal is to launch 16 fully electric cars by 2022, and sales of the new Mustang Mach-E have been strong so far.GM plans to spend $27 billion, up from a prior target of $20 billion, and aims to launch 30 new EVs around the world by 2025 across its luxury and mass-market brands.GM's transformation has drawn particular attention. \"We believe investors should prepare for a profound narrative change at GM put into action in 2021,\" Morgan Stanley analyst Adam Jonas wrote in a January note.That month, GM revealed a new and potentially disruptive EV business, called BrightDrop, focused on the delivery and logistics market.But the linchpin of its EV strategy is the Ultium battery technology, which GM says will support a range of 450 miles on a single charge while reducing costs and weight. A next-generation Ultium platform is already in the works to extend the range to 600 miles.\"We will seize every opportunity to drive growth, expand our markets and enter new ones,\" CEO Mary Barra said Feb. 10. \"Our Ultium platform is core to these initiatives. It is the foundation for our upcoming global family of EVs.\"EV Battery And Charging CompaniesCompanies making vehicles aren't the only EV stocks for investors to watch. Other companies make car batteries and car charging stations. Among them are new IPO stocks Blink Charging and QuantumScape in 2020. ChargePoint debuted March 1. Rival EVgo will go public via blank-check firm Climate Change Crisis Real Impact I Acquisition Corp. in Q2 under the ticker EVGO.Meanwhile, Hyliion will start shipping its electric powertrain for big-rig trucks, with a claimed range of 1,000 miles. It's also developing powertrains that can be compatible with renewable natural gas and hydrogen fuel cells.Romeo Power makes battery packs for commercial EV fleets. Other names are Enovix and Microvast, which are coming public via SPAC mergers.QuantumScape appears to have achieved a major breakthrough in developing solid-state lithium metal batteries. The batteries promise to be safer and cheaper, have a longer life span, charge faster and have more energy density than existing lithium ion batteries.On Feb. 16, the Bill Gates- and Volkswagen-backed startup revealed it can produce multilayered battery cells. Its four-layer battery is still short of the 12 or so needed to be commercially viable. But the company is confident enough in its ability to make progress that it decided to build a \"pre-pilot\" production facility to make \"enough batteries for hundreds of long-range battery electric test vehicles per year\" by 2023.\"The company has shown its battery cell can charge up to 80% of capacity in 15 minutes, which would be a 'game changer' if this scales at mass volumes,\" Wedbush analyst Dan Ives wrote in a recent note.It's Not Just Tesla StockFor now, Tesla stock is 30% below its intraday record, has given back all its gains so far this year, and is below the price when it debuted on the S&P 500. Its recent dive below the 50-day line was a sell signal, according to IBD Leaderboard.But Ives, a prominent Tesla stock bull, said in a March 4 note that \"the EV party and transformation is just beginning,\" adding that a \"green tidal wave\" is on the horizon as EV adoption speeds up.He also predicted the electric-vehicle industry could balloon to a $5 trillion market over the next decade. That's up from about $250 billion in 2020.And that growth forecast also applies to the legacy auto giants, Ives wrote, pointing to the likes of GM and Ford \"jumping into the deep end of the pool on EVs.\"In an interview Dec. 29, Ives suggested it's not just going to be Tesla's world. \"It's an ocean of opportunities,\" Ives told IBD. \"There's room for more than one boat.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320868979,"gmtCreate":1615080707991,"gmtModify":1704778496744,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Low blow","listText":"Low blow","text":"Low blow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320868979","repostId":"1100698985","repostType":4,"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320109659,"gmtCreate":1615031408871,"gmtModify":1704778293706,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320109659","repostId":"1111997538","repostType":4,"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320109875,"gmtCreate":1615031393597,"gmtModify":1704778293222,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/320109875","repostId":"1123272188","repostType":4,"isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":367927913,"gmtCreate":1614905295032,"gmtModify":1704776774352,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Setback&nbsp;","listText":"Setback&nbsp;","text":"Setback","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/367927913","repostId":"2117980502","repostType":4,"repost":{"id":"2117980502","pubTimestamp":1614898658,"share":"https://www.laohu8.com/m/news/2117980502?lang=&edition=full","pubTime":"2021-03-05 06:57","market":"us","language":"en","title":"Apple faces EU charges over Spotify complaint: Sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2117980502","media":"The Straits Times","summary":"BRUSSELS  - Apple could face an EU antitrust charge sheet in the coming weeks after a complaint by rival Spotify that it unfairly pushed its own music streaming service, two people familiar with the matter said on Thursday .The European Commission could send the statement of objections setting out suspected violations of the bloc's antitrust rules to Apple before the summer, $one$ of the people said.The case is $one$ of four opened by the EU competition enforcer against Apple in June last year. ","content":"<div>\n<p>BRUSSELS (REUTERS) - Apple could face an EU antitrust charge sheet in the coming weeks after a complaint by rival Spotify that it unfairly pushed its own music streaming service, two people familiar ...</p>\n\n<a href=\"http://www.straitstimes.com/world/europe/apple-faces-eu-charges-over-spotify-complaint-sources\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple faces EU charges over Spotify complaint: Sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple faces EU charges over Spotify complaint: Sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-05 06:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/europe/apple-faces-eu-charges-over-spotify-complaint-sources><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRUSSELS (REUTERS) - Apple could face an EU antitrust charge sheet in the coming weeks after a complaint by rival Spotify that it unfairly pushed its own music streaming service, two people familiar ...</p>\n\n<a href=\"http://www.straitstimes.com/world/europe/apple-faces-eu-charges-over-spotify-complaint-sources\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"http://www.straitstimes.com/world/europe/apple-faces-eu-charges-over-spotify-complaint-sources","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117980502","content_text":"BRUSSELS (REUTERS) - Apple could face an EU antitrust charge sheet in the coming weeks after a complaint by rival Spotify that it unfairly pushed its own music streaming service, two people familiar with the matter said on Thursday (March 4).\nThe European Commission could send the statement of objections setting out suspected violations of the bloc's antitrust rules to Apple before the summer, one of the people said.\nThe case is one of four opened by the EU competition enforcer against Apple in June last year. The EU charge sheet usually indicates whether a fine is merited and what companies have to do to halt anti-competitive practices.\nThe Commission declined to comment.\nApple referred to its March 2019 blog which said its App Store helped Spotify to benefit from hundreds of millions of app downloads to become Europe's largest music streaming service.\nSpotify in its 2019 complaint to the Commission said Apple unfairly restricts rivals to its own music steaming service Apple Music and also protested against the 30 per cent fee levied on app developers to use Apple's in-app purchase system (IAP).\nIn addition to the Spotify case, the Commission is also investigating Apple's App Stores rules for all competing apps, for e-books and audio books as well as its terms and conditions for its mobile payment service Apple Pay.\nThe UK competition watchdog on Thursday opened an investigation into Apple's practices while the Dutch agency is close to a decision on its own case.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364190250,"gmtCreate":1614820569370,"gmtModify":1704775619292,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"EVs are the future. Watch this space.&nbsp;","listText":"EVs are the future. Watch this space.&nbsp;","text":"EVs are the future. Watch this space.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364190250","repostId":"1102082323","repostType":4,"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364104630,"gmtCreate":1614820458220,"gmtModify":1704775616022,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm, not sure about this.&nbsp;","listText":"Hmmm, not sure about this.&nbsp;","text":"Hmmm, not sure about this.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364104630","repostId":"2116152999","repostType":4,"repost":{"id":"2116152999","pubTimestamp":1614812749,"share":"https://www.laohu8.com/m/news/2116152999?lang=&edition=full","pubTime":"2021-03-04 07:05","market":"sg","language":"en","title":"Facebook ends ban on political advertising across its network","url":"https://stock-news.laohu8.com/highlight/detail?id=2116152999","media":"The Straits Times","summary":"SAN FRANCISCO (NYTIMES) - Facebook said it planned to lift its ban on political advertising across i","content":"<div>\n<p>SAN FRANCISCO (NYTIMES) - Facebook said it planned to lift its ban on political advertising across its network, resuming a form of digital promotion that has been criticised for spreading ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/facebook-ends-ban-on-political-advertising-across-its-network\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Facebook ends ban on political advertising across its network</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFacebook ends ban on political advertising across its network\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-04 07:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/united-states/facebook-ends-ban-on-political-advertising-across-its-network><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SAN FRANCISCO (NYTIMES) - Facebook said it planned to lift its ban on political advertising across its network, resuming a form of digital promotion that has been criticised for spreading ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/facebook-ends-ban-on-political-advertising-across-its-network\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"http://www.straitstimes.com/world/united-states/facebook-ends-ban-on-political-advertising-across-its-network","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2116152999","content_text":"SAN FRANCISCO (NYTIMES) - Facebook said it planned to lift its ban on political advertising across its network, resuming a form of digital promotion that has been criticised for spreading misinformation, falsehoods and inflaming voters.The social network said on Wednesday (March 3) that it would allow advertisers to buy new ads about \"social issues, elections or politics\" beginning Thursday, according to a copy of an e-mail sent to political advertisers and viewed by The New York Times.Those advertisers must complete a series of identity checks before being authorised to place the ads, the company said.\"We put this temporary ban in place after the November 2020 election to avoid confusion or abuse following Election Day,\" Facebook said in a blog post. \"We've heard a lot of feedback about this and learnt more about political and electoral ads during this election cycle. As a result, we plan to use the coming months to take a closer look at how these ads work on our service to see where further changes may be merited.\"Mr Mark Zuckerberg, Facebook's chief executive, has said he wished to maintain a largely hands-off stance towards speech on the site unless it posed an immediate harm to the public or individuals.Former president Donald Trump used Facebook's political ads to amplify claims about an \"invasion\" on the Mexican border in 2019, among other incidents.Facebook banned political ads late last year as a way to choke off misinformation and threats of violence around the November presidential election.In January, Facebook banned Mr Trump from using his account and posting on the platform after he took to social media to delegitimise the election results and incited a violent uprising among his supporters, who stormed the US Capitol.Facebook said Mr Trump's suspension was indefinite. The decision is under review by the Facebook Oversight Board, a third-party entity created by the company and composed of journalists, academics and others that adjudicates some of the company's thorny content policy enforcement decisions. A decision is expected within the next few months.On Thursday, political advertisers on Facebook will be able to submit new ads or turn on existing political ads that have already been approved, the company said. Each ad will appear with a small disclaimer.","news_type":1},"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364104394,"gmtCreate":1614820429318,"gmtModify":1704775615857,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"This is progress and innovation!! Will we see more of this in other countries also?","listText":"This is progress and innovation!! Will we see more of this in other countries also?","text":"This is progress and innovation!! Will we see more of this in other countries also?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364104394","repostId":"2116311521","repostType":4,"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364105872,"gmtCreate":1614820387096,"gmtModify":1704775614706,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364105872","repostId":"2116521315","repostType":4,"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364105071,"gmtCreate":1614820371493,"gmtModify":1704775614216,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Here we go!","listText":"Here we go!","text":"Here we go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364105071","repostId":"1107788140","repostType":4,"repost":{"id":"1107788140","pubTimestamp":1614816795,"share":"https://www.laohu8.com/m/news/1107788140?lang=&edition=full","pubTime":"2021-03-04 08:13","market":"us","language":"en","title":"Wall Street drops as high-flying tech stocks retreat","url":"https://stock-news.laohu8.com/highlight/detail?id=1107788140","media":"Reuters","summary":"(Reuters) - The Nasdaq ended sharply lower on Wednesday after investors sold high-flying technology ","content":"<p>(Reuters) - The Nasdaq ended sharply lower on Wednesday after investors sold high-flying technology shares and pivoted to sectors viewed as more likely to benefit from an economic recovery on the back of fiscal stimulus and vaccination programs.</p><p>Microsoft Corp, Apple Inc and Amazon.com Inc dropped more than 2%, weighing more than any other stocks on the S&amp;P 500.</p><p>The S&amp;P 500 financial and industrial sector indexes reached intra-day record highs. Most other S&amp;P 500 sectors declined.</p><p>“Today is the perfect encapsulation of the big theme we’ve been seeing in the past couple of months: The vaccine rollout is going well and the economy improving, and that is sending yields and rate expectations higher, which is hurting growth stocks,” said Baird investment strategist Ross Mayfield, in Louisville, Kentucky.</p><p>The Dow Jones Industrial Average fell 0.39% to end at 31,270.09 points, while the S&amp;P 500 lost 1.31% to 3,819.72.</p><p>The Nasdaq Composite dropped 2.7% to 12,997.75. That left it at its lowest since early January and reduced its gain in 2021 to less than 1%.</p><p>The U.S. economic recovery continued at a modest pace over the first weeks of this year, with businesses optimistic about the months to come and demand for housing “robust,” but only slow improvement in the job market, the Federal Reserve reported.</p><p>While the vaccine distribution is expected to help the economy, data showed U.S. private employers hired fewer workers than expected in February, suggesting the labor market was struggling to regain speed.</p><p>Another report showed U.S. services industry activity unexpectedly slowed in February amid winter storms, while a measure of prices paid by companies for inputs surged to the highest level in nearly 12-1/2 years.</p><p>The U.S. 10-year Treasury yield ticked up to 1.47%, pressuring areas of the market with high valuations. It was still off last week’s peak of above 1.61% that roiled stock markets as investors bet on rising inflation.</p><p>Rising interest rates disproportionately hurt high-growth tech companies because investors value them based on earnings expected years into the future, and high interest rates hurt the value of future earnings more than the value of earnings made in the short term.</p><p>“There is a definite headwind for equity markets if yields go above the 1.5% level with most investors keeping an eye on the pace of yield growth,” said Michael Stritch, chief investment officer at BMO Wealth Management.</p><p>President Joe Biden’s proposed $1.9 trillion coronavirus relief bill would phase out $1,400 payments to high-income Americans in a compromise with moderate Democratic senators, according to lawmakers and media reports.</p><p>Exxon Mobil Corp rose 0.8% after the oil major unveiled plans to grow dividends and curb spending with projections that were less bold than previous years.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.95-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 62 new 52-week highs and no new lows; the Nasdaq Composite recorded 284 new highs and 68 new lows.</p><p>Volume on U.S. exchanges was 14 billion shares, compared with the 14.9 billion average for the full session over the last 20 trading days.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street drops as high-flying tech stocks retreat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street drops as high-flying tech stocks retreat\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-04 08:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/us-usa-stocks/wall-street-drops-as-high-flying-tech-stocks-retreat-idUSKBN2AV1EG><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The Nasdaq ended sharply lower on Wednesday after investors sold high-flying technology shares and pivoted to sectors viewed as more likely to benefit from an economic recovery on the back...</p>\n\n<a href=\"https://www.reuters.com/article/us-usa-stocks/wall-street-drops-as-high-flying-tech-stocks-retreat-idUSKBN2AV1EG\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果"},"source_url":"https://www.reuters.com/article/us-usa-stocks/wall-street-drops-as-high-flying-tech-stocks-retreat-idUSKBN2AV1EG","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107788140","content_text":"(Reuters) - The Nasdaq ended sharply lower on Wednesday after investors sold high-flying technology shares and pivoted to sectors viewed as more likely to benefit from an economic recovery on the back of fiscal stimulus and vaccination programs.Microsoft Corp, Apple Inc and Amazon.com Inc dropped more than 2%, weighing more than any other stocks on the S&P 500.The S&P 500 financial and industrial sector indexes reached intra-day record highs. Most other S&P 500 sectors declined.“Today is the perfect encapsulation of the big theme we’ve been seeing in the past couple of months: The vaccine rollout is going well and the economy improving, and that is sending yields and rate expectations higher, which is hurting growth stocks,” said Baird investment strategist Ross Mayfield, in Louisville, Kentucky.The Dow Jones Industrial Average fell 0.39% to end at 31,270.09 points, while the S&P 500 lost 1.31% to 3,819.72.The Nasdaq Composite dropped 2.7% to 12,997.75. That left it at its lowest since early January and reduced its gain in 2021 to less than 1%.The U.S. economic recovery continued at a modest pace over the first weeks of this year, with businesses optimistic about the months to come and demand for housing “robust,” but only slow improvement in the job market, the Federal Reserve reported.While the vaccine distribution is expected to help the economy, data showed U.S. private employers hired fewer workers than expected in February, suggesting the labor market was struggling to regain speed.Another report showed U.S. services industry activity unexpectedly slowed in February amid winter storms, while a measure of prices paid by companies for inputs surged to the highest level in nearly 12-1/2 years.The U.S. 10-year Treasury yield ticked up to 1.47%, pressuring areas of the market with high valuations. It was still off last week’s peak of above 1.61% that roiled stock markets as investors bet on rising inflation.Rising interest rates disproportionately hurt high-growth tech companies because investors value them based on earnings expected years into the future, and high interest rates hurt the value of future earnings more than the value of earnings made in the short term.“There is a definite headwind for equity markets if yields go above the 1.5% level with most investors keeping an eye on the pace of yield growth,” said Michael Stritch, chief investment officer at BMO Wealth Management.President Joe Biden’s proposed $1.9 trillion coronavirus relief bill would phase out $1,400 payments to high-income Americans in a compromise with moderate Democratic senators, according to lawmakers and media reports.Exxon Mobil Corp rose 0.8% after the oil major unveiled plans to grow dividends and curb spending with projections that were less bold than previous years.Declining issues outnumbered advancing ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.95-to-1 ratio favored decliners.The S&P 500 posted 62 new 52-week highs and no new lows; the Nasdaq Composite recorded 284 new highs and 68 new lows.Volume on U.S. exchanges was 14 billion shares, compared with the 14.9 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":18,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":368374932,"gmtCreate":1614296927026,"gmtModify":1704770258323,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yet another setback for FB","listText":"Yet another setback for FB","text":"Yet another setback for FB","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/368374932","repostId":"1124529867","repostType":4,"repost":{"id":"1124529867","pubTimestamp":1614245782,"share":"https://www.laohu8.com/m/news/1124529867?lang=&edition=full","pubTime":"2021-02-25 17:36","market":"us","language":"en","title":"Facebook, Netflix Face Fresh Scrutiny as India Tightens Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=1124529867","media":"Bloomberg","summary":"India reins in social media, streaming with new guidelines\nCountry joins the fray in targeting Silic","content":"<ul>\n <li>India reins in social media, streaming with new guidelines</li>\n <li>Country joins the fray in targeting Silicon Valley giants</li>\n</ul>\n<p>India joined the global regulatory push to rein in Silicon Valley technology giants, tightening rules that govern how social media and streaming companies do business in the world’s biggest democracy.</p>\n<p>The new rules will require the likes of&nbsp;Facebook Inc.&nbsp;and&nbsp;Twitter Inc.&nbsp;to take down unlawful content quicker, Minister Ravi Shankar Prasad said in an online briefing Thursday. Streaming services such as&nbsp;Netflix Inc., Google’s YouTube and&nbsp;Amazon.com Inc.‘s Prime Video face stricter rules over content.</p>\n<p>Already under scrutiny from Australia and Europe to their home turf of the U.S., the tech giants can now add their most important emerging market to the list of countries whose regulators are paying closer attention. Policy changes have the potential to slow down the companies in a market that’s already the largest for some of them in terms of the number of users.</p>\n<p>The new rules replace a previous code from 2011. Draft versions that have been circulating recently have attracted criticism from freedom-of-speech activists and technology trade groups concerned the rules will result in increased censorship and reduced user privacy.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Facebook, Netflix Face Fresh Scrutiny as India Tightens Rules</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFacebook, Netflix Face Fresh Scrutiny as India Tightens Rules\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-25 17:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-02-25/facebook-netflix-face-fresh-scrutiny-as-india-tightens-rules><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>India reins in social media, streaming with new guidelines\nCountry joins the fray in targeting Silicon Valley giants\n\nIndia joined the global regulatory push to rein in Silicon Valley technology ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-02-25/facebook-netflix-face-fresh-scrutiny-as-india-tightens-rules\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞","TWTR":"Twitter"},"source_url":"https://www.bloomberg.com/news/articles/2021-02-25/facebook-netflix-face-fresh-scrutiny-as-india-tightens-rules","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124529867","content_text":"India reins in social media, streaming with new guidelines\nCountry joins the fray in targeting Silicon Valley giants\n\nIndia joined the global regulatory push to rein in Silicon Valley technology giants, tightening rules that govern how social media and streaming companies do business in the world’s biggest democracy.\nThe new rules will require the likes of Facebook Inc. and Twitter Inc. to take down unlawful content quicker, Minister Ravi Shankar Prasad said in an online briefing Thursday. Streaming services such as Netflix Inc., Google’s YouTube and Amazon.com Inc.‘s Prime Video face stricter rules over content.\nAlready under scrutiny from Australia and Europe to their home turf of the U.S., the tech giants can now add their most important emerging market to the list of countries whose regulators are paying closer attention. Policy changes have the potential to slow down the companies in a market that’s already the largest for some of them in terms of the number of users.\nThe new rules replace a previous code from 2011. Draft versions that have been circulating recently have attracted criticism from freedom-of-speech activists and technology trade groups concerned the rules will result in increased censorship and reduced user privacy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3559787818034959","authorId":"3559787818034959","name":"Ericlam","avatar":"https://static.tigerbbs.com/f2154f4bb8afd22f8e6fde60b57acb69","crmLevel":7,"crmLevelSwitch":1},"content":"Price keep dropping","text":"Price keep dropping","html":"Price keep dropping"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320868688,"gmtCreate":1615080757744,"gmtModify":1704778497238,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Woah","listText":"Woah","text":"Woah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/320868688","repostId":"1172045569","repostType":4,"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320109875,"gmtCreate":1615031393597,"gmtModify":1704778293222,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/320109875","repostId":"1123272188","repostType":4,"isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320868979,"gmtCreate":1615080707991,"gmtModify":1704778496744,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Low blow","listText":"Low blow","text":"Low blow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320868979","repostId":"1100698985","repostType":4,"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320109659,"gmtCreate":1615031408871,"gmtModify":1704778293706,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320109659","repostId":"1111997538","repostType":4,"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366959656,"gmtCreate":1614386766775,"gmtModify":1704771420286,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great news!!","listText":"Great news!!","text":"Great news!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/366959656","repostId":"2114371822","repostType":4,"repost":{"id":"2114371822","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614335051,"share":"https://www.laohu8.com/m/news/2114371822?lang=&edition=full","pubTime":"2021-02-26 18:24","market":"us","language":"en","title":"Pfizer COVID-19 vaccine reduces transmission after one dose -UK study","url":"https://stock-news.laohu8.com/highlight/detail?id=2114371822","media":"Reuters","summary":"LONDON, Feb 26  - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare ","content":"<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer COVID-19 vaccine reduces transmission after one dose -UK study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer COVID-19 vaccine reduces transmission after one dose -UK study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-26 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2114371822","content_text":"LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.\nResearchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.\n“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.\nAfter separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.\nThis compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.\nThe study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.\nThis suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.\nThe level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.\nBritain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.\n“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”\nKey real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320600626,"gmtCreate":1615086673965,"gmtModify":1704778559721,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320600626","repostId":"2117639609","repostType":4,"repost":{"id":"2117639609","pubTimestamp":1614957600,"share":"https://www.laohu8.com/m/news/2117639609?lang=&edition=full","pubTime":"2021-03-05 23:20","market":"us","language":"en","title":"What's the Outlook for Intuitive Surgical?","url":"https://stock-news.laohu8.com/highlight/detail?id=2117639609","media":"Jason Hawthorne","summary":"Competition is heating up, but the company's market leadership remains unchallenged.","content":"<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, <b>Intuitive</b> <b>Surgical</b> (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"</p><p>After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>The arms of a surgical robot. Image source: Getty Images.</p><p><b>Managing through COVID-19</b></p><p>Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.</p><p>Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.</p><p>Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.</p><p>Although this is definitely a concern, it's a temporary <a href=\"https://laohu8.com/S/AONE\">one</a>. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.</p><p><b>A changing regulatory landscape</b></p><p>In recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.</p><p>One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.</p><p><b>Defending the moat</b></p><p>One of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by <b>Meere</b> back in 2017.</p><p>Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers <b>Medtronic</b> (NYSE:MDT) and <b>Johnson</b> <b>&amp;</b> <b>Johnson</b> (NYSE:JNJ).</p><p>Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.</p><p>Johnson &amp; Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.</p><p>First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to <b>Stryker</b> and <b>Smith</b> <b>&amp;</b> <b>Nephew</b>, not Intuitive.</p><p>Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.</p><p>And third, Johnson &amp; Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.</p><p><b>Clear skies, with a few clouds on the horizon</b></p><p>Despite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.</p><p>As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's the Outlook for Intuitive Surgical?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's the Outlook for Intuitive Surgical?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-05 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/><strong>Jason Hawthorne</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize","relate_stocks":{"ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117639609","content_text":"After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, Intuitive Surgical (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.The arms of a surgical robot. Image source: Getty Images.Managing through COVID-19Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.Although this is definitely a concern, it's a temporary one. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.A changing regulatory landscapeIn recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.Defending the moatOne of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by Meere back in 2017.Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ).Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.Johnson & Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to Stryker and Smith & Nephew, not Intuitive.Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.And third, Johnson & Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.Clear skies, with a few clouds on the horizonDespite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.","news_type":1},"isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365616457,"gmtCreate":1614734437779,"gmtModify":1704774566035,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Healthy pullback","listText":"Healthy pullback","text":"Healthy pullback","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/365616457","repostId":"2116515986","repostType":4,"repost":{"id":"2116515986","pubTimestamp":1614725573,"share":"https://www.laohu8.com/m/news/2116515986?lang=&edition=full","pubTime":"2021-03-03 06:52","market":"sg","language":"en","title":"US stocks retreat, extending volatile run","url":"https://stock-news.laohu8.com/highlight/detail?id=2116515986","media":"The Straits Times","summary":"NEW YORK (AFP) - Wall Street stocks fell on Tuesday (March 2), giving back a portion of the gains fr","content":"<div>\n<p>NEW YORK (AFP) - Wall Street stocks fell on Tuesday (March 2), giving back a portion of the gains from the prior session's rally as investors girded for more volatility.\nThe yield on the 10-year US ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/us-stocks-retreat-extending-volatile-run\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US stocks retreat, extending volatile run</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS stocks retreat, extending volatile run\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-03 06:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/us-stocks-retreat-extending-volatile-run><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (AFP) - Wall Street stocks fell on Tuesday (March 2), giving back a portion of the gains from the prior session's rally as investors girded for more volatility.\nThe yield on the 10-year US ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/us-stocks-retreat-extending-volatile-run\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"source_url":"http://www.straitstimes.com/business/companies-markets/us-stocks-retreat-extending-volatile-run","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2116515986","content_text":"NEW YORK (AFP) - Wall Street stocks fell on Tuesday (March 2), giving back a portion of the gains from the prior session's rally as investors girded for more volatility.\nThe yield on the 10-year US Treasury note continued to decline on Tuesday, but investors are grappling with the chance that inflation could rise if President Joe Biden's US$1.9 trillion (S$2.5 trillion) stimulus plan is passed.\n\"The Fed still wants to continue this easy money policy,\" said JJ Kinahan, chief market strategist at TD Ameritrade, who said many investors fear inflation or view the economy as well on its way to recovery.\n\"The policy makers and the market are having a little bit of a tug of war,\" Kinahan said.\nThe Dow Jones Industrial Average fell 0.5 per cent to 31,391.52.\nThe broad-based S&P 500 dropped 0.8 per cent to 3,870.29, while the tech-rich Nasdaq Composite Index tumbled 1.7 per cent to 13,358.95.\nAmong individual companies, Target slumped 6.8 per cent despite reporting a 66 per cent jump in fourth-quarter income to US$1.4 billion on another round of surging sales amid the coronavirus pandemic.\nHowever, investors were caught off guard by the big-box chain's announcement to spend US$4 billion on more store and e-commerce upgrades.\nRocket Companies, a personal finance firm, surged more than 70 per cent, in the latest rally prompted by investors on social media company Reddit's WallStreetBets.","news_type":1},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365618634,"gmtCreate":1614734373228,"gmtModify":1704774564223,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Rally!","listText":"Rally!","text":"Rally!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/365618634","repostId":"1187509414","repostType":4,"repost":{"id":"1187509414","pubTimestamp":1614730102,"share":"https://www.laohu8.com/m/news/1187509414?lang=&edition=full","pubTime":"2021-03-03 08:08","market":"sg","language":"en","title":"Wall Street ends lower as Apple and Tesla retreat","url":"https://stock-news.laohu8.com/highlight/detail?id=1187509414","media":"reuters","summary":" - Wall Street ended lower on Tuesday, pulled down by Apple and Tesla, while materials stocks climbed as investors waited for the U.S. Congress to approve another stimulus package.Following strong gains in the prior session, technology shares dipped in the resumption of a rotation by investors out of stocks that outperformed due to the coronavirus pandemic and into others viewed as likely to do well as the economy recovers. The S&P 500 materials and consumer staples sector indexes rose.“Part of ","content":"<p>(Reuters) - Wall Street ended lower on Tuesday, pulled down by Apple and Tesla, while materials stocks climbed as investors waited for the U.S. Congress to approve another stimulus package.</p><p>Following strong gains in the prior session, technology shares dipped in the resumption of a rotation by investors out of stocks that outperformed due to the coronavirus pandemic and into others viewed as likely to do well as the economy recovers. The S&amp;P 500 materials and consumer staples sector indexes rose.</p><p>Yields on the benchmark 10-year Treasury bonds have stabilized after hitting a <a href=\"https://laohu8.com/S/AONE.U\">one</a>-year high last week.</p><p>“Part of it is just because technology went up so much last year, and if interest rates are on the rise then the value of their future cash flows is diminished,” said Tom Hainlin, global investment strategist at U.S. Bank Wealth Management.</p><p>The S&amp;P 500 on Monday logged its best day since June as markets cheered approval of a third COVID-19 vaccine in the United States and the U.S. House of Representatives’ green light for a $1.9 trillion coronavirus relief package.</p><p>The U.S. Senate will start debating President Joe Biden’s relief bill this week when Democrats aim to pass the legislation through a maneuver known as “reconciliation,” which would allow the bill to pass with a simple majority.</p><p>Apple dipped about 2% and Tesla declined more than 4%, with the two companies contributing the most to the S&amp;P 500’s loss for the day.</p><p>The S&amp;P 500 technology sector index dropped 1.6%, extending a pullback from late last month after a selloff in the U.S. bond market sparked fears over highly valued stocks. The consumer discretionary index dipped 1.3%, with Amazon falling 1.6%.</p><p>The Dow Jones Industrial Average fell 0.46% to end at 31,391.52 points, while the S&amp;P 500 lost 0.81% to 3,870.29.</p><p>The Nasdaq Composite dropped 1.69% to 13,358.79.</p><p>The Russell 2000 index of smaller companies declined 1.9%, trimming its gain in 2021 to about 13%, compared with the S&amp;P 500’s rise of 3% in the same period.</p><p>Heavily shorted mortgage provider <a href=\"https://laohu8.com/S/RKT\">Rocket Companies</a> surged 71% in its third straight day of gains as the stock drew interest on Reddit’s popular WallStreetBets.</p><p>Kohl’s Corp rose 0.6% after it posted holiday-quarter results beyond market expectations on a boost in online sales and as the company reined in costs.</p><p>TV ratings provider Nielsen jumped 7.6% after it sold its advanced video advertising business to television streaming platform provider Roku. Shares of Roku dropped 7.3%.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 1.36-to-1 ratio; on Nasdaq, a 2.64-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 30 new 52-week highs and no new lows; the Nasdaq Composite recorded 165 new highs and 57 new lows.</p><p>Volume on U.S. exchanges was 12.3 billion shares, compared with the 14.9 billion average for the full session over the last 20 trading days.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends lower as Apple and Tesla retreat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends lower as Apple and Tesla retreat\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-03 08:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/us-usa-stocks/wall-street-ends-lower-as-apple-and-tesla-retreat-idUSKBN2AU19P><strong>reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street ended lower on Tuesday, pulled down by Apple and Tesla, while materials stocks climbed as investors waited for the U.S. Congress to approve another stimulus package.Following ...</p>\n\n<a href=\"https://www.reuters.com/article/us-usa-stocks/wall-street-ends-lower-as-apple-and-tesla-retreat-idUSKBN2AU19P\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.reuters.com/article/us-usa-stocks/wall-street-ends-lower-as-apple-and-tesla-retreat-idUSKBN2AU19P","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187509414","content_text":"(Reuters) - Wall Street ended lower on Tuesday, pulled down by Apple and Tesla, while materials stocks climbed as investors waited for the U.S. Congress to approve another stimulus package.Following strong gains in the prior session, technology shares dipped in the resumption of a rotation by investors out of stocks that outperformed due to the coronavirus pandemic and into others viewed as likely to do well as the economy recovers. The S&P 500 materials and consumer staples sector indexes rose.Yields on the benchmark 10-year Treasury bonds have stabilized after hitting a one-year high last week.“Part of it is just because technology went up so much last year, and if interest rates are on the rise then the value of their future cash flows is diminished,” said Tom Hainlin, global investment strategist at U.S. Bank Wealth Management.The S&P 500 on Monday logged its best day since June as markets cheered approval of a third COVID-19 vaccine in the United States and the U.S. House of Representatives’ green light for a $1.9 trillion coronavirus relief package.The U.S. Senate will start debating President Joe Biden’s relief bill this week when Democrats aim to pass the legislation through a maneuver known as “reconciliation,” which would allow the bill to pass with a simple majority.Apple dipped about 2% and Tesla declined more than 4%, with the two companies contributing the most to the S&P 500’s loss for the day.The S&P 500 technology sector index dropped 1.6%, extending a pullback from late last month after a selloff in the U.S. bond market sparked fears over highly valued stocks. The consumer discretionary index dipped 1.3%, with Amazon falling 1.6%.The Dow Jones Industrial Average fell 0.46% to end at 31,391.52 points, while the S&P 500 lost 0.81% to 3,870.29.The Nasdaq Composite dropped 1.69% to 13,358.79.The Russell 2000 index of smaller companies declined 1.9%, trimming its gain in 2021 to about 13%, compared with the S&P 500’s rise of 3% in the same period.Heavily shorted mortgage provider Rocket Companies surged 71% in its third straight day of gains as the stock drew interest on Reddit’s popular WallStreetBets.Kohl’s Corp rose 0.6% after it posted holiday-quarter results beyond market expectations on a boost in online sales and as the company reined in costs.TV ratings provider Nielsen jumped 7.6% after it sold its advanced video advertising business to television streaming platform provider Roku. Shares of Roku dropped 7.3%.Declining issues outnumbered advancing ones on the NYSE by a 1.36-to-1 ratio; on Nasdaq, a 2.64-to-1 ratio favored decliners.The S&P 500 posted 30 new 52-week highs and no new lows; the Nasdaq Composite recorded 165 new highs and 57 new lows.Volume on U.S. exchanges was 12.3 billion shares, compared with the 14.9 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":361069598,"gmtCreate":1614179445214,"gmtModify":1704889219088,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good read ?","listText":"Good read ?","text":"Good read ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/361069598","repostId":"1129467108","repostType":4,"repost":{"id":"1129467108","pubTimestamp":1614164417,"share":"https://www.laohu8.com/m/news/1129467108?lang=&edition=full","pubTime":"2021-02-24 19:00","market":"us","language":"en","title":"Why J.P. Morgan Says Now Is the Time to Bet on the S&P 500","url":"https://stock-news.laohu8.com/highlight/detail?id=1129467108","media":"Barrons","summary":"Don’t worry. Be greedy.Even though investor fears are rising, and the stock market is getting bullie","content":"<p>Don’t worry. Be greedy.</p><p>Even though investor fears are rising, and the stock market is getting bullied by rising bond yields,J.P. Morganstrategists have told their clients that now is the time to embrace stocks.</p><p>TheS&amp;P 500may be waffling around 3875, but the bank is standing by its 2021 year-end price target of 4400 on a range of 4200 to 4600. Its numbers aren’t merely some derivative of the stock market’s expected earnings. Instead, they reflect America’s economic reawakening after the Covid-19 pandemic.</p><p>Shawn Quigg, a J.P. Morgan derivatives strategist, recently told clients that there is little to stand in the way of the market’s achievement of “such gains sooner than later, particularly considering the numerous catalysts ahead, their impact on volatility, and the implications that will have on investor positioning.”</p><p>As President Joe Biden’s administration&nbsp;champions a $1.9 trillion stimulus program, and Covid-19 infections and hospitalizations decline, Quigg anticipates stocks surging. His view is somewhat at odds with recent trading. Stocks have declined as the 10-year Treasury note yield has increased to about 1.38%, a move&nbsp;that is fanning inflation fearsand worries about stock slumps.</p><p>Quigg likes taking advantage of the fear and the pending stimulus program, which Biden has begun to defend against concerns that it is too large. In various interviews, the president has challenged critics to tell him what to cut at a time when so much of the nation is suffering. The Biden administration is now warning that the greatest risk isn’t a large stimulus package, but one that is too small and thus doesn’t meaningfully stimulate economic growth.</p><p>To position for the stock market to surge higher, Quigg advised clients to consider selling one of the&nbsp;SPDR S&amp;P 500 ETF‘s (ticker: SPY) May $353 put options and buying 15 May $450 call options. When the ETF was at $392.39, the leveraged risk-reversal strategy—that is,selling one put and buying many more calls&nbsp;with a higher strike price but the same expiration—could be done for no cost. In other words, the money received for selling the put was enough to buy 15 bullish calls.</p><p>The trade expresses high conviction that the ETF—which was recently trading around $387—will reach $450 by May 21, when May options expire. At $460, the call is worth $10.</p><p>Should the ETF decline, say, because current fears push the market below the $353 strike price, investors would be obligated to buy it at the lower price, or to cover or adjust the puts.</p><p>Quigg’s trade idea has a lot to admire.</p><p>For one, the trade carried zero cost when it was recommended late last week. Yes, prices have moved since the Feb. 18 note was published, but investors can recast strike prices to create similar pricing. The markets change, and that’s why there are so many different strike prices that are listed.</p><p>Moreover, if J.P. Morgan’s base view of the economic reawakening proves true, owning a bundle of upside calls that cost nothing could be quite lucrative. Should the market succumb to the current fears that are weakening prices, owning S&amp;P 500 stocks at lower prices isn’t terrible, either.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why J.P. Morgan Says Now Is the Time to Bet on the S&P 500</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy J.P. Morgan Says Now Is the Time to Bet on the S&P 500\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-24 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/why-j-p-morgan-says-now-is-the-time-to-bet-on-the-s-p-500-51614090217?mod=RTA><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Don’t worry. Be greedy.Even though investor fears are rising, and the stock market is getting bullied by rising bond yields,J.P. Morganstrategists have told their clients that now is the time to ...</p>\n\n<a href=\"https://www.barrons.com/articles/why-j-p-morgan-says-now-is-the-time-to-bet-on-the-s-p-500-51614090217?mod=RTA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/why-j-p-morgan-says-now-is-the-time-to-bet-on-the-s-p-500-51614090217?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129467108","content_text":"Don’t worry. Be greedy.Even though investor fears are rising, and the stock market is getting bullied by rising bond yields,J.P. Morganstrategists have told their clients that now is the time to embrace stocks.TheS&P 500may be waffling around 3875, but the bank is standing by its 2021 year-end price target of 4400 on a range of 4200 to 4600. Its numbers aren’t merely some derivative of the stock market’s expected earnings. Instead, they reflect America’s economic reawakening after the Covid-19 pandemic.Shawn Quigg, a J.P. Morgan derivatives strategist, recently told clients that there is little to stand in the way of the market’s achievement of “such gains sooner than later, particularly considering the numerous catalysts ahead, their impact on volatility, and the implications that will have on investor positioning.”As President Joe Biden’s administration champions a $1.9 trillion stimulus program, and Covid-19 infections and hospitalizations decline, Quigg anticipates stocks surging. His view is somewhat at odds with recent trading. Stocks have declined as the 10-year Treasury note yield has increased to about 1.38%, a move that is fanning inflation fearsand worries about stock slumps.Quigg likes taking advantage of the fear and the pending stimulus program, which Biden has begun to defend against concerns that it is too large. In various interviews, the president has challenged critics to tell him what to cut at a time when so much of the nation is suffering. The Biden administration is now warning that the greatest risk isn’t a large stimulus package, but one that is too small and thus doesn’t meaningfully stimulate economic growth.To position for the stock market to surge higher, Quigg advised clients to consider selling one of the SPDR S&P 500 ETF‘s (ticker: SPY) May $353 put options and buying 15 May $450 call options. When the ETF was at $392.39, the leveraged risk-reversal strategy—that is,selling one put and buying many more calls with a higher strike price but the same expiration—could be done for no cost. In other words, the money received for selling the put was enough to buy 15 bullish calls.The trade expresses high conviction that the ETF—which was recently trading around $387—will reach $450 by May 21, when May options expire. At $460, the call is worth $10.Should the ETF decline, say, because current fears push the market below the $353 strike price, investors would be obligated to buy it at the lower price, or to cover or adjust the puts.Quigg’s trade idea has a lot to admire.For one, the trade carried zero cost when it was recommended late last week. Yes, prices have moved since the Feb. 18 note was published, but investors can recast strike prices to create similar pricing. The markets change, and that’s why there are so many different strike prices that are listed.Moreover, if J.P. Morgan’s base view of the economic reawakening proves true, owning a bundle of upside calls that cost nothing could be quite lucrative. Should the market succumb to the current fears that are weakening prices, owning S&P 500 stocks at lower prices isn’t terrible, either.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364190250,"gmtCreate":1614820569370,"gmtModify":1704775619292,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"EVs are the future. Watch this space.&nbsp;","listText":"EVs are the future. Watch this space.&nbsp;","text":"EVs are the future. Watch this space.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364190250","repostId":"1102082323","repostType":4,"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364104394,"gmtCreate":1614820429318,"gmtModify":1704775615857,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"This is progress and innovation!! Will we see more of this in other countries also?","listText":"This is progress and innovation!! Will we see more of this in other countries also?","text":"This is progress and innovation!! Will we see more of this in other countries also?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364104394","repostId":"2116311521","repostType":4,"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365612877,"gmtCreate":1614734473599,"gmtModify":1704774566860,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Maybe some issue?","listText":"Maybe some issue?","text":"Maybe some issue?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/365612877","repostId":"2116751302","repostType":4,"isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320862574,"gmtCreate":1615080904598,"gmtModify":1704778500513,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Makes sense","listText":"Makes sense","text":"Makes sense","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320862574","repostId":"2117201682","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364104630,"gmtCreate":1614820458220,"gmtModify":1704775616022,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm, not sure about this.&nbsp;","listText":"Hmmm, not sure about this.&nbsp;","text":"Hmmm, not sure about this.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364104630","repostId":"2116152999","repostType":4,"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365616233,"gmtCreate":1614734411822,"gmtModify":1704774565870,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow ?&nbsp;","listText":"Wow ?&nbsp;","text":"Wow ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365616233","repostId":"2116516818","repostType":4,"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321016080,"gmtCreate":1615385012940,"gmtModify":1704781980446,"author":{"id":"3577252837038057","authorId":"3577252837038057","name":"PhilM","avatar":"https://static.tigerbbs.com/1e97ce6c1e5016e5cff48014808ffbcb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Thanks to J&amp;J’ vaccine. Just one doze!&nbsp;","listText":"Thanks to J&amp;J’ vaccine. Just one doze!&nbsp;","text":"Thanks to J&J’ vaccine. Just one doze!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321016080","repostId":"1129292669","repostType":4,"repost":{"id":"1129292669","pubTimestamp":1615384190,"share":"https://www.laohu8.com/m/news/1129292669?lang=&edition=full","pubTime":"2021-03-10 21:49","market":"us","language":"en","title":"Biden administration to buy an additional 100 million doses of J&J's Covid vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1129292669","media":"cnbc","summary":"The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two admi","content":"<div>\n<p>The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two administration sources told NBC News.、\nPresident Joe Biden will announce the plans Wednesday during a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden administration to buy an additional 100 million doses of J&J's Covid vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden administration to buy an additional 100 million doses of J&J's Covid vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-10 21:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two administration sources told NBC News.、\nPresident Joe Biden will announce the plans Wednesday during a ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.cnbc.com/2021/03/10/jj-covid-vaccine-biden-administration-to-buy-an-additional-100-million-doses.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1129292669","content_text":"The U.S. plans to buy 100 million additional doses of Johnson & Johnson's Covid-19 vaccine, two administration sources told NBC News.、\nPresident Joe Biden will announce the plans Wednesday during a White House meeting with executives from J&J and Merck.\nJ&J currently has a deal with the U.S. government to provide 100 million doses by the end of June. The federal government shipped out nearly 3.9 million doses of the single-shot vaccine last week and says it plans to distribute 16 million more by the end of this month.\nThe announcement comes as the administration works to ramp up the production of J&J’s vaccine after it learned earlier in the year that the company had fallen behind in vaccine production.\nThe New York Times first reported in January that unexpected manufacturing delays would lead to a reduced initial supply of J&J’s drug if it were given emergency authorization.\nLast week,Biden announced that pharmaceutical giant Merck would help make J&J’s Covid vaccine. Under the arrangement, Merck will dedicate two facilities in the U.S. to J&J’s vaccine. One will make the vaccine and the other will provide “fill-finish” services, when the vaccine is placed in vials.\nWhite House Chief Medical Advisor Dr. Anthony Fauci said last month he was “disappointed” with the number of doses initially expected from J&J, adding the federal government thought there would be “considerably more.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}